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resumo 
 
 
Os vidros e vitrocerâmicos bioactivos são uma classe de biomateriais que 
induzem uma resposta especial à sua superfície quando em contacto com 
fluidos biológicos que conduz a uma forte ligação ao tecido vivo. Esta 
característica particular conjugada com uma boa aptidão para a sinterização e 
elevada resistência mecânica torna estes materiais ideais para a fabricação de 
estruturas de suporte à regeneração óssea. O trabalho apresentado nesta tese 
pretende dar um contributo para uma melhor compreensão das relações entre 
composição-estrutura-propriedades em vidros potencialmente bioactivos com 
composições no sistema CaOMgOP2O5SiO2F, em alguns casos com a 
adição de Na2O. O estudo da influência exercida pela composição do vidro na 
estrutura molecular, capacidade de sinterização e nível de bioactividade dos 
vidros fosfosilicatados foi objecto de especial atenção. As composições vítreas 
foram concebidas no campo da cristalização primária do pseudo sistema 
ternário do diópsido (CaO•MgO•2SiO2) – fluorapatite (9CaO•3P2O5•CaF2) – 
wollastonite, e estudou-se o impacto das variações composicionais na 
estrutura, nas propriedades e na capacidade de sinterização destes vidros. 
Todos os vidros investigados neste trabalho foram preparados por fusão e 
fritagem e caracterizados quanto à sua estrutura molecular, capacidade de 
sinterização, degradação química e bioactividade, usando uma grande 
variedade de técnicas experimentais. Ficou demonstrado que em todas as 
composições de vidro investigadas a rede de silicato era dominada 
principalmente por unidades Q
2
 enquanto o fosfato se encontrava coordenado 
em ambiente de ortofosfato. As composições de biovidros isentas de alcalinos 
do sistema diópsido–fluorapatite demonstram possuir excelente capacidade de 
sinterização e elevados níveis de bioactividade, atributos que os qualificam 
como materiais promissores para a fabricação de estruturas de suporte à 
regeneração de tecidos ósseos, enquanto os vidros bioactivos contendo 
alcalinos foram mais difíceis de densificar durante a sinterização e induziram 
citotoxicidade in vitro, não sendo candidatos ideais para a engenharia de 
tecidos. Uma das nossas composições de biovidro com um baixo teor de sódio 
foi testada com sucesso tanto in vivo como em ensaios clínicos preliminares. 
Mas este trabalho precisa de ser continuado e aprofundado. A dispersão de 
fritas moídas em meio aquoso ou outros solventes adequados, e o estudo dos 
factores mais relevantes que condicionam a reologia das suspensões são 
etapas essenciais para viabilizar o processo de fabrico de suportes porosos 
com estruturas hierárquicas de poros feitas por medida através de técnicas de 
processamento avançadas tais como o Robocasting. 
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abstract 
 
Bioactive glasses and glass–ceramics are a class of biomaterials which elicit 
special response on their surface when in contact with biological fluids, leading 
to strong bonding to living tissue. This particular trait along with good sintering 
ability and high mechanical strength make them ideal materials for scaffold 
fabrication. The work presented in this thesis is directed towards understanding 
the composition-structure-property relationships in potentially bioactive glasses 
designed in CaOMgOP2O5SiO2F system, in some cases with added Na2O. 
The main emphasis has been on unearthing the influence of glass composition 
on molecular structure, sintering ability and bioactivity of phosphosilicate 
glasses. The parent glass compositions have been designed in the primary 
crystallization field of the pseudo-ternary system of diopside (CaO•MgO•2SiO2) 
– fluorapatite (9CaO•3P2O5•CaF2) – wollastonite (CaO•SiO2), followed by 
studying the impact of compositional variations on the structure-property 
relationships and sintering ability of these glasses. All the glasses investigated 
in this work have been synthesized via melt-quenching route and have been 
characterized for their molecular structure, sintering ability, chemical 
degradation and bioactivity using wide array of experimental tools and 
techniques. It has been shown that in all investigated glass compositions the 
silicate network was mainly dominated by Q
2
 units while phosphate in all the 
glasses was found to be coordinated in orthophosphate environment. The glass 
compositions designed in alkali-free region of diopside – fluorapatite system 
demonstrated excellent sintering ability and good bioactivity in order to qualify 
them as potential materials for scaffold fabrication while alkali-rich bioactive 
glasses not only hinder the densification during sintering but also induce 
cytotoxicity in vitro, thus, are not ideal candidates for in vitro tissue engineering. 
One of our bioglass compositions with low sodium content has been tested 
successfully both in vivo and in preliminary clinical trials. But this work needs to 
be continued and deepened. The dispersing of fine glass particles in aqueous 
media or in other suitable solvents, and the study of the most important factors 
that affect the rheology of the suspensions are essential steps to enable the 
manufacture of porous structures with tailor-made hierarchical pores by 
advanced processing techniques such as Robocasting. 
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A lot of advancement has been made in the field of glass science and as a result, glass 
materials have found applications in various technological domains, thus, improving the quality 
of human life. Some of the most common examples of glasses being used in different 
technological applications include: Float Glass (mainly soda-lime silica), Gorilla
®
 (chemically 
strengthened, alkali-alkaline-earth aluminosilicate), Eagle
®
 (alkaline-earth aluminosilicate), 
Pyrex
®
 (low thermal expansion borosilicate) and, Borosil
®
 (borosilicate). However, there also 
exist wide ranges of glass compositions which are used in various other important technological 
applications but are not known to common man. Some of the most prominent examples for such 
application include: radioactive waste immobilization, human biomedicine, specialty sealing and 
optical fibers. 
The application of glasses as ‘biomaterials’ is one such area which has revolutionized the 
field of human biomedicine and has brought the concept of ‘surface active’ materials which have 
the ability to elicit a special response on its surface when in contact with biological fluids, 
leading to strong bonding to living bone 
or tissue [1]. The concept of ‘bioactive’ 
or surface active glasses/ceramics was 
introduced by Professor Larry L. Hench 
at University of Florida in late 1960s by 
the discovery of 45S5 Bioglass
®
 with 
its chemical composition designed 
close to the eutectic of soda-lime silica 
ternary system (mol.%: 46.1SiO2 – 
26.9CaO – 24.4 Na2O – 2.5 P2O5) 
(Figure 1.1) [2]. Since its discovery, 
45S5 Bioglass
® 
has been used in 
>650,000 human patients and is being 
marketed for various dental and orthopedic applications under different commercial brand 
names, for example: PerioGlass
® 
and NovaBone
®
 [1-3]. This has led to a considerable effort 
towards understanding the fundamental science governing the chemical, thermal and other 
properties of bioactive glasses based on – or – inspired by 45S5 Bioglass® so that novel glasses 
with enhanced biological efficacy can be designed [4-9].  
Figure 1.1. Ternary phase diagram of Na2O-
CaO-SiO2 system depicting the glass forming 
region of 45S5 Bioglass
®
 [2]. 
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Despite its huge success, 45S5 Bioglass
®
 (and other bioactive glasses with high alkali-
content) has some inherent drawbacks which do not warrant its application in some of the most 
advanced areas of human biomedicine, for example: in vitro tissue engineering. In vitro tissue 
engineering involves the manipulation of cells in vitro on porous scaffolds, prior to implantation 
into the in vivo environment [10]. Accordingly, an ideal porous scaffold is expected to exhibit 
good biocompatibility with controlled dissolution behaviour and should be able to balance the 
temporary mechanical function with mass transport to aid biological delivery and tissue 
regeneration in three dimensions (3D) [11]. Interestingly, 45S5 Bioglass
®
 does not meet the 
abovementioned pre-requisites due to its: (i) poor sintering ability and high crystallization 
tendency which convert it into a bio-inert glass-ceramic with poor mechanical strength [12, 13], 
(ii) high chemical dissolution in aqueous solutions and body fluids leading to sudden changes in 
pH environment (due to alkali outburst), thus, resulting in apoptosis in vitro [14].  
Another potentially viable candidate for the task of scaffold fabrication is apatite-
wollastonite (A/W) glass-ceramic (CERABONE
®
 A-W) developed by Kokubo et al. [15], along 
the pseudo ternary system 3CaO•P2O5  CaO•SiO2  MgO•CaO•2SiO2 and comprising of 38 
wt.% apatite [Ca10(PO4)6(O, F2)], 24 wt.% wollastonite (CaSiO3) and 28 wt.% residual glassy 
phase. The glass-ceramic is known to exhibit good sintering ability, high mechanical strength 
(flexural strength: 215 MPa and Young´s modulus: 118 GPa) and good bioactivity. Despite these 
salient features, the glass-ceramic scaffolds derived from this composition still are not suitable 
materials for scaffold fabrication mainly due to their slow degradation (owing to their high 
crystalline content, especially high apatite content with high chemical durability), often taking 
some years to disappear from the body [16]. The slow degradation of glass-ceramic scaffold may 
lead to reduction in its effective pore size by in vivo events such as the invasion of fibrous tissue 
into the pores and the nonspecific adsorption of proteins onto the material’s surface. 
Therefore, there is an exigent need to design low – or – negligible alkali content silicate 
glasses with controlled chemical dissolution, good sintering ability, high mechanical strength and 
excellent bioactive properties suitable for scaffold fabrication for their application in tissue 
engineering. However, the design of a multicomponent glass composition exhibiting the above-
mentioned desired properties cannot be accomplished through trial-and-error approach as it 
needs an in-depth understanding of fundamental science governing the various macroscopic 
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properties of the potentially bioactive glass systems. Accordingly, the work reported in this 
dissertation has been directed towards fulfilment of the following aims: 
1. To understand the glass forming region in alkali-free CaO – MgO – P2O5 – SiO2 – F 
system.  
2. To understand composition – structure – property relationships in phosphosilicate 
bioactive glasses. 
3. To understand the sintering mechanism in alkaline-earth phosphosilicate bioactive 
glasses and its implications on the bioactivity of the resultant glass-ceramic. 
4. To understand the impact of compositional variation on the structure, chemical 
durability, thermal stability and bioactivity of these glasses. 
We hope that the work reported in this dissertation will be a good contribution to the growing 
knowledge base in the field of biomaterials and will be helpful in designing materials with novel 
applications in the field of human biomedicine.    
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2.1 Biomaterials 
A biomaterial is a natural or synthetic material to be used in intimate contact with living 
tissue. In 1986, at the Consensus Conference of the European Society for Biomaterials, 
biomaterial was defined as “a nonviable material used in a medical device, intended to interact 
with biological systems” [1]. Synthetic biomaterials have been broadly classified into three 
separate categories, on the basis of the strength of the response that the exposure of the implant 
to a biological medium elicits in the living environment (Figure 2.1) [2, 3]. 
Bio-inert or First-generation biomaterials, developed during the 1960s and 1970s, are 
metals or alloys (titanium, stainless steel, cobalt–chrome) and dense or porous ceramics 
(Al2O3 or alumina and ZrO2 or zirconia). They are bioinert, owing to their absent or weak 
interaction with living tissues upon implant: in the 
past, the minimal response from the host was in 
fact considered a desirable feature of any 
biomaterial for use inside the human body. 
Following contact with biological fluids, inert 
biomaterials are encapsulated within a non-
adherent, fibrous layer of variable thickness. The 
implant–tissue interaction is essentially of 
mechanical nature, as the material can be cast and 
pressed in place to yield a suitably tight fit: this 
result in a very thin fibrous layer, which is crucial 
for the success of inert implants, as it reduces 
relative movement at the implant–tissue interface. 
Interfacial movement under external stress leads to 
loosening and deterioration of the mechanical fit, which causes pain and eventually leads to 
clinical failure of bioinert implants [2]. While porous ceramics can achieve a better mechanical 
fit thanks to tissue in-growth in the micropores [4], the absence of a real chemical adhesion with 
the tissues, combined with the reduction in strength inherent to the porous structure, limits their 
long-term durability in porous ceramic implants as well, and they have found applications mostly 
as bone spacers and scaffolds.  
Figure 2.1 Classification of 
biomaterials according to their 
bioactivity (a) bioinert alumina dental 
implant, (b) bioactive hydroxyapatite 
[Ca10(PO4)6(OH)2] coating on a 
metallic dental implant, (c) surface 
active bioglass and (d) bioresorbable 
tricalcium phosphate ([Ca3(PO4)2] [3] 
impant. 
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The opposite case of bio-inert materials is represented by resorbable or completely 
biodegradable materials, such as calcium phosphates, either crystalline or amorphous, which are 
rapidly dissolved upon exposure to physiological fluids, and gradually replaced with living 
tissues [5, 6]. This procedure is, in principle, ideal, being based on the natural ability of bone and 
muscles to self-heal and regenerate, but is complicated by the need to match the rates of implant 
dissolution and tissue growth; while the implant is being replaced by new tissue, its strength will 
progressively decrease, and a very unstable interface will result, requiring immobilization of the 
patient for long periods. 
Surface-active or bioactive materials represent an ideal compromise between these two 
limits: after implant, a bioactive material rapidly forms a stable bond with the tissues through a 
reactive surface layer. The chemical nature of this bond considerably enhances the interfacial 
adhesion of the implant; at the same time, the reactivity of bioactive materials is limited to their 
surface, owing to progressive passivation by the surface layer, which does not allow further 
degradation to progress rapidly to the bulk material, and therefore a stable interface is maintained 
long enough to favour further cellular interaction and induce controlled growth of mature tissues. 
Several biomaterials belong to this category: the first bioactive materials were discovered 
by Hench et al. (1971) ca 40 years ago [7]; they showed that specific compositions of melt-
derived Na2O–CaO–SiO2–P2O5 glasses can form a strong bond with hard (bone) and in some 
cases soft (muscle and tendons) connective tissues, through a sequence of rapid chemical 
processes that follow their implant in vivo or the in vitro contact with a physiological test 
solution. Until few years back, it was well accepted and agreed that the key feature which leads 
to the bone-bonding ability of bioactive glasses (and of bioactive materials in general), is the 
formation of a film of crystalline hydroxyapatite (HA) on their surface. Since  HA is the mineral 
component of bone, its presence on the glass surface was considered to promote further cellular 
steps, such as incorporation of collagen and interaction with other biomolecules and tissue 
growth factors, which then favour the development of a biological bond with the tissues [2, 8-
10]. However, recent literature suggests that formation of HA layer on the glass surface is not 
critical for the bioactivity of the material [11] as the ionic dissolution products from the bioactive 
glasses/ceramics appear to stimulate the growth and differentiation of cells at the genetic level 
[12], an effect which has been considered to be dose dependent [13, 14]. Despite the controversy 
surrounding the importance of HA layer formation on the surface of bioactive glasses/ceramics, 
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it still enjoys the support of the scientific community and is considered to be the marker of 
bioactivity during initial screening of biomaterials [15]. Therefore, we shall follow this protocol 
for the work reported in this dissertation.  
 
2.2 Bioactive materials 
Bioactive materials have been classified in two different sets namely, ‘Class A’ and 
‘Class B’. Class A bioactivity is ‘The process whereby a biological surface is colonized by 
osteogenic stem cells free in the defect environment as a result of surgical intervention’. An 
extra- as well as intracellular response is elicited by a ‘Class A’ bioactive material at the 
interface. Such materials are said to be osteoproductive. ‘Class B’ bioactivity is a bioinductive 
pathway that allows bone to grow along it, thus, the material only exhibits an extracellular 
response at the interface. Such materials are known as osteoconductive [16]. Bioactive glasses 
and glass-ceramics are typical examples of ‘Class A’ biomaterials. The development in the field 
of bioactive glasses has not yet reached its potential and research activity in this field if still 
growing as is evident from these recent review articles [9, 14, 17-20]  
 
2.3 Compositional and structural design of bioactive glasses 
Glass network former 
Until today, bioactive 
glasses have been designed in 
borate [21-23], phosphate [6, 24] 
and silicate [7, 25, 26] glass 
systems. However, silicate glasses 
have always received considerable 
attention in comparison to the 
other two systems mainly due to 
their higher chemical and thermal 
stability which allows easy 
synthesis and processing of these 
glasses and provides flexibility to 
tailor their chemical compositions 
Figure 2.2 Compositional dependence of bioactivity in 
Na2O-CaO-SiO2-P2O5 glass system. 
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in order to achieve desired properties. Also it has been reported that release of silica species from 
the bioactive glasses in the range of 0.1 ppm to 100 ppm exhibits stimulatory effects on the 
osteoblasts and the expression of TGF- mRNA in human osteoblast-like cells [27].  
Several studies on the chemical dissolution and bioactivity of different glass 
compositions in the silicate glass system have led to the establishment of an empirical model 
describing the relationship between the chemical composition and bioactivity of silicate glasses 
wherein a glass with SiO2 content varying between 45 – 52 wt.% exhibits highest bioactivity. In 
this compositional range, a bonding both to soft and hard connective tissue occurs within 5-10 
days. Bioactive glasses and glass-ceramics containing 55 – 60 wt.% SiO2 require a longer time to 
form a bond with bones and do not bond to soft tissues. Glass compositions with >60 wt.% SiO2 
do not bond either to bone or soft tissues, and elicit formation of a non-adherent fibrous 
interfacial capsule [28]. Figure 2.2 exhibits the compositional dependence of bioactivity in the 
silicate glasses designed in soda-lime silica system. It is noteworthy that this composition-
bioactivity relationship has been established for glasses synthesized through melt-quenched route 
and may not be considered valid for sol-gel glasses as HA formation on the surface of glasses 
with 90 mol% SiO2 content has been observed in this case when in contact with SBF solution 
[29]. These differences in bioactivity of melt-quenched glasses versus sol-gel glasses are due to 
different surface chemistry of the two systems considering the high amount of inherent porosity 
and molecular water present in the sol-gel glasses [29]. 
From the structural viewpoint, it has been well established that molecular structure of 
glasses plays a crucial role in deciding their bioactivity. For example, the high level of 
bioactivity in 45S5 Bioglass
®
 is known to arise from a structure dominated by chains of Q
2
 
metasilicates, which are occasionally cross-linked through Q
3
 units, whereas Q
1
 species 
terminate the chains, where Q
n
 species distribution furnishes a measure of the connectivity of the 
glass network and the index n refers to the number of bridging oxygens (BOs) surrounding 
network former ions [30]. Similarly, the enhanced dissolution of silica in highly bioactive 
compositions has also been found to be closely related to the significant fraction of Q
1
 (Si) chain 
terminators while moderate bioactivity can be achieved when Q
3
 (Si) structures predominate 
[30].  
The incorporation of P2O5 in silicate-based bioactive glasses induces significant structural 
changes as has been elucidated by experimental [31, 32] as well as computational studies [33], 
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thus, impacting the overall bioactivity of the glass system. The physiological response of silicate-
based bioactive glasses is known to depend critically on both the P2O5 content and silicate 
network connectivity (NC). Since network modifying cations have higher affinity for phosphate 
groups, incorporating P2O5 in bioactive glasses strips the network modifying cations out of 
silicate glass network, thus inducing re-polymerization. Therefore, substantial fraction of P2O5 in 
bioactive glass may increase its network connectivity (NC), thus exhibiting negative impact on 
its bioactivity. On the other hand, P2O5 when added in small concentrations (2 – 10 mol.%) 
coordinates itself predominantly in orthophosphate environment (Q
0
 (P)) and does not participate 
to form the part of actual glass network backbone [34, 35]. Structural studies on compositionally 
complex bioactive glasses are yet to be reported. While the bioactivity generally displays a non-
monotonic dependence of P2O5 concentration, literature suggests that it is merely the net 
orthophosphate content that directly links to the bioactivity [34-36]. 
 
Glass network modifier 
 The choice of glass network modifiers for the design of bioactive glasses has been mainly 
confined to alkali and alkaline-earth oxides because of their ability to tailor the molecular 
structure of glasses to achieve desired properties and more importantly owing to their biological 
significance. For example: calcium is the main component of human bone and its importance in 
bone mineralization process and effect on cell specific responses has been well established [37]. 
It is due to this reason that CaO has become an integral component of bioactive glasses. 
However, it is difficult to obtain a stable melt-quenched glasses from CaOSiO2 binary system 
due to their higher tendency towards crystallization. This problem has been overcome by 
incorporation of alkali oxides in the glasses which not only create non-bridging oxygens in the 
silicate glass structure but also expand the glass forming region from CaOSiO2 binary system 
to soda-lime-silica ternary system as shown in Fig. 2.2. As mentioned in Chapter 1: 
Introduction, the 45S5 Bioglass
®
 composition has been designed near the eutectic of soda-lime 
silica system (which was the original basis of selecting this composition for investigation by 
Hench et al. [16]) but far from the typical compositions of soda-lime glasses, which contain 
much more silica.  
Despite being the primary cation in extracellular fluids in animals and humans (sodium: 
135-145 mmol l
-1
 and potassium: 3.6 – 5.1 mmol l-1) and their importance in generation of nerve 
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impulses, finer regulation of the fluid balance, regulating blood volume, blood pressure, osmotic 
equilibrium and pH, the influence of alkali-ions on the bioactivity of silicate glasses has been 
rarely studied. According to Wallace et al. [38], incorporating sodium ions in silicate glasses 
induces cytotoxicity in vitro thus, resulting in apoptosis. Similar observations have also been 
reported in our recent study where sodium-free glass composition exhibited the highest cell 
viability and proliferation on its surface while incorporation of 2-10 mol.% Na2O in silicate 
glasses resulted in apoptosis over a duration of 7 – 14 days [39]. The reason for this behavior 
has been explained on the basis of Na:Ca ratio and their mutual interaction in glasses in Chapter 
4. Interestingly, 45S5 Bioglass
®
 contains 24-25 mol.% Na2O, still it has been used in >650,000 
human patients [9] owing to the ability of the human renal system to get rid of all the excess 
sodium in order to maintain osmo-regulation.  However, these observations raise serious 
concerns for application of alkali-containing bioactive glasses in in vitro tissue engineering. 
Further, the fast dissolution behavior [40] and poor sintering ability [41] of glasses with high 
alkali-content (>10 mol.%), for example: 45S5 Bioglass, renders them unfit for their aqueous 
processing and scaffold fabrication.  Therefore, in order to design glasses with controlled 
dissolution behavior, good sintering ability and minimal cytotoxicity in vitro, their alkali 
content needs to be well optimized.  
Apart from sodium and calcium, another cation which though is non-essential for the 
bioactive glass design but plays crucial role in enhancing their biological efficacy is magnesium 
(Mg
2+
). Magnesium is the fourth most abundant cation in human body with an estimated 1 mole 
of magnesium stored in the body of a normal 70 kg adult, with approximately half of the total 
physiological magnesium stored in bone tissue [42]. It is essential to bone metabolism and has 
been shown to have stimulating effects on new bone formation [43]. Magnesium is a co-factor 
for many enzymes, and stabilizes the structures of DNA and RNA. Rude et al. [44, 45] observed 
that magnesium depletion results in impaired bone growth, increased bone resorption and loss in 
trabecular bone underlining the significant role that magnesium plays in bone metabolism. The 
level of magnesium in the extracellular fluid ranges between 17 ppm and 25.5 ppm, where 
homeostasis is maintained by the kidneys and intestine [42, 46]. Although magnesium levels 
exceeding 25.5 ppm can lead to muscular paralysis, hypotension and respiratory distress and 
cardiac arrest occurs for severely high serum levels of 145–170 ppm, the incidence of hyper-
magnesium is rare due to the efficient excretion of the element in the urine [42, 46, 47]. One 
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important factor that leads to the incorporation of magnesium in bioactive glasses is its ability to 
increase their fracture toughness and lower their Young’s modulus [48, 49]. 
From structural viewpoint, the influence of magnesium on structure of glasses has been 
well described in literature [36, 48, 50-54]. MgO is considered to behave like CaO (i.e. network 
modifier) within a silicate glass structure [54] but its elemental properties such as charge to size 
ratio and Pauling electronegativity suggest that Mg
2+
 falls on the boundary between being a 
network modifier and an intermediate oxide [51]. Accordingly, the structural coordination of 
magnesium in silicate glasses has been shown to depend on glass chemistry as it has been found 
to exist in 4-, 5- and 6- fold coordination in these glasses. Pedone et al. (using molecular 
dynamic simulations) found magnesium to exist in four-coordination in a silica-rich (SiO2 = 75 
mol.%) soda lime silica glass [49] while it was found to exist in five-coordination in 45S5 
Bioglass
®
 [48] and also in alkali-free bioactive glasses [55]. The overall network connectivity 
and number of non-bridging oxygens (NBOs) remained unchanged with varying CaO/MgO ratio. 
Similar results have been obtained by Watts et al. [51] while experimentally investigating the 
influence of CaO/MgO ratio on the structure and thermal properties of soda-lime silica based 
bioactive glasses. Further, it has been reported that among sodium, calcium and magnesium ions, 
Mg
2+
 has the least affinity to associate with phosphate component in a bioactive glass possibly 
due to its role as an intermediate [48, 55]. 
The influence of magnesium on the in vitro bioactivity has been reported for both melt-
quenched and sol-gel derived glasses [52, 53, 56-61]. Magnesium is known to associate 
preferentially to phosphorus at the glass surface thus, making the surface of glass poorer in 
calcium (in comparison to bulk) which slows down (but not hinder) the apatite forming ability 
of glasses when immersed in SBF solution due to lack of apatitic nucleation domains [52, 53, 
56]. However, considering the influence of ionic dissolution products at the genetic level and 
importance of magnesium in bone regeneration and tissue engineering, the retardation in the HA 
layer formation on bioactive glass surface may be ignored. Similar observations have been 
reported for strontium and zinc incorporation in the bioactive glasses [55, 62]. 
 
Intermediates 
 Al2O3 and TiO2 are the two most common intermediate oxides that have been used in 
design of bioactive glass compositions [63-66]. Since both these oxides have been shown to 
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increase the chemical durability of glasses (thus, decreasing their bioactivity), their usage (if any) 
in bioactive glass compositions has been confined to small amounts i.e. 1 – 2 mol.%. It is 
noteworthy that apatite-mullite glass-ceramics (containing significant amount of Al2O3) have 
been found biocompatible in vivo (not in vitro) [67]. However, most of the Al2O3 in these glass-
ceramics is concentrated in crystalline regions of the final product and these materials exhibit 
very slow chemical degradation behaviour. Similarly, TiO2 has been used in significant amounts 
in phosphate based bioactive glasses as it slows down their chemical degradation in body fluids 
and tailor bioactivity [68-70]. All the glasses studied in our work are Al2O3- and TiO2- free. 
 
Additives 
 Several inorganic functional ions (for example, Sr
2+
, Zn
2+
, Cu
2+
, F
-
, etc.) might be added 
to the glass compositions in trace quantities in order to design gene-activating bioactive glasses 
with controlled release of functional ions tailored for specific patients and disease states. For 
example, although the amount of strontium in the skeleton is only 0.335% of its calcium content 
[71], its important role in  treatment of osteoporosis by promoting bone regeneration through 
osteoblast replication has resulted in development of strontium containing bioactive glasses for 
orthopaedic applications  [62, 72-76]. Similarly, owing to their favourable attributes, fluoride-
releasing biomaterials are being considered for their potential applications in various fields of 
biomedicine, especially dentistry and orthopaedics [77, 78]. Fluoride is known to increase bone 
density and also acts as an anti-carcinogenic agent [78-80]. Also, intracellular or plaque-
associated enzymes have been reported to be affected by fluoride ions [77].  
There are several challenges that need to be addressed while incorporating fluoride in 
silicate glasses including their high volatility during glass melting [81] and lower solubility in 
silicate glasses. Brauer et al. [81] synthesized soda-lime phosphosilicate based bioactive glasses 
containing 0 – 17.76 mol% CaF2 and found that 5 – 23% CaF2 is lost during synthesis of glasses 
via melt-quench route (higher the fluoride content, more is the loss). At molecular level, the 
structural role of fluoride in silicate glasses depends mainly on the local environment in glasses. 
For example, in fluorinated silica (SiO2) glass, fluoride tends to bond only to silicon (≡Si-F) to 
form SiO3F tetrahedra with no evidence for the formation of oxyfluorides [82-84]. In silicates, 
the acidic environment in these glasses induces greater amount of Si–F bonds while basic 
environments favour the formation of M–F (where, M is a network modifier cation) aggregates 
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as has been shown by Hayakawa et al. [85]. Since 
the overall environment in silicate/phosphosilicate 
bioactive glasses is basic in nature (due to the 
presence of Na
+
, Ca
2+
, Mg
2+
, Sr
2+
, etc.), fluoride is 
mainly found associated with alkali/alkaline-earth 
cations forming ionic aggregates (CaF
+
, SrF
+
) as 
has been shown by Kapoor et al. [86] and  Lusvardi 
et al. (Figure 2.3) [87]. The ability of fluoride ion 
to strip network modifying cations (from the glass 
network may force the silicate network to re-
polymerize by forming Si–O–Si or Si–O–P bonds 
(depending on the fluoride and phosphate 
concentration in the glass), thus, increasing the 
network connectivity.  
Although considerable amount of literature 
is available describing the influence of fluoride on 
molecular structure and chemical dissolution behaviour of silicate and phosphosilicate glasses 
[26, 81, 87-90], there is no consensus on its impact on hydroxyapatite formation and in vitro 
bioactivity of glasses. All the glasses investigated studied in this work contain fluoride in minor 
amounts.  
 
2.4 Sintering behaviour of bioactive glasses – Its implications on scaffold fabrication for 
tissue engineering 
Tissue engineering is an interdisciplinary field that applies the principles of engineering 
and life sciences toward the development of biological substitutes that restore, maintain, or 
improve tissue function or a whole organ [91]. Tissue engineering involves the expansion of 
cells from a small biopsy followed by the culturing of cells in temporary three-dimensional (3D) 
scaffolds to form a new organ or tissue. The primary function of a scaffold for hard tissues 
engineering is its role as the substratum that allows cells to attach, proliferate, differentiate (i.e., 
transform from a non-specific or primitive state into cells exhibiting the bone specific functions), 
and organize into normal, healthy bone as the scaffold degrades. Therefore, this new paradigm 
 
Figure 2.3 Snapshot of the glass 
structure for fluorinated-45S5 
Bioglass
®
 where 15 mol.% CaO has 
been substituted by equivalent 
concentration of CaF2. The micro-
segregation zone of network modifiers 
(Ca and Na) with fluoride ion can be 
seen in white circle. [87] 
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requires scaffolds that balance temporary mechanical function with mass transport to aid 
biological delivery and tissue regeneration in three dimensions (3D) [92]. The synthetic scaffold, 
once seeded with cells, should be as short lived as possible; however, the scaffold must maintain 
its viability and integrity long enough for the cells to produce their own extracellular matrix. 
Therefore, a major consideration when designing a scaffold for tissue engineering is the scaffold 
material. 
During fabrication of glass-ceramic scaffolds, the success of the fabrication process 
depends mainly on the sintering 
ability of glass powders as, in 
order to obtain a mechanically 
strong glass-ceramic scaffold, 
viscous flow sintering should 
precede crystallization. 
Furthermore, although 
crystallization in glasses might 
be required to enhance the 
mechanical strength of scaffolds, 
too high crystalline content 
(> 90 wt.%) in glass-ceramics 
can turn the material to be bio-
inert [93]. Thus, it becomes 
highly crucial to optimize the 
sintering conditions of the glass 
powder so as to achieve equilibrium in the midst of biological and mechanical properties of the 
final material.  
Most of the studies on sintering of bioactive glasses have focused on understanding the 
thermal transformations in 45S5 Bioglass
®
 [94-101]. According to Lefebvre et al. [100], five 
successive transformations occur during heating of 45S5 Bioglass
®
 powder from room 
temperature to 1000 ºC at a heating rate of 5 ºC min
1
: (1) Glass transition (Tg1) at 550 ºC [101] 
(Figure 2.4), (2) glass-in-glass phase separation at 580 ºC, (3) surface crystallization of 
Na2CaSi2O6 at 610 ºC from silica rich phase, (4) crystallization of Na2Ca4(PO4)2SiO4 from 
Figure 2.4. Differential thermal analysis (DTA) scan of 
45S5 Bioglass at 5 ºC min
-1
 [101]. 
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phosphate rich phase at 800 ºC, (5) second glass transition (Tg2) of the remaining glassy phase. 
The sintering of 45S5 Bioglass
®
 exhibits two main shrinkage stages associated with two glass 
transition temperatures. The crystallization of Na2CaSi2O6 at 610 ºC immediately after glass-in-
glass phase separation completely inhibits the sintering of this glass, thus, leading to the 
formation of a non-sintered, porous, mechanically weak and crystalline glass powder compact. In 
fact it has been reported that crystallization of 45S5 Bioglass
®
 turns this glass into an inert 
material [99, 102]. Although three-dimensional porous, fully crystallized glass-ceramic scaffolds 
have been obtained from 45S5 Bioglass
®
 after sintering at 1000 ºC for 1 h, the compressive and 
bending strength of the as produced scaffolds has been reported to be 0.30.4 and 0.40.5 MPa, 
respectively [98]. These values are significantly lower than the compressive strength of apatite-
wollastonite based glass-ceramics scaffolds i.e. 5 MPa for a scaffold with 75% total porosity 
[103]. The 45S5 Bioglass
®
 glass-ceramic scaffolds have been shown to exhibit hydroxyapatite 
formation on their surface after 28 days of immersion in simulated body fluid (SBF) [98, 99] 
which in itself is a marker of their low bioactivity level. Further attempts are being made to 
optimize the recipe for fabrication of mechanically strong but amorphous scaffolds from 45S5 
Bioglass
®
 by solid freeform fabrication techniques [104, 105], the small sintering window of this 
glass poses a big challenge in this arduous task. 
 Another glass composition that has been most widely and successfully used as a glass-
ceramic biomaterial is CERABONE
®
 A-W developed by Kokubo et al. [106] along the pseudo 
ternary system 3CaO∙P2O5 - CaO∙SiO2 - CaO∙MgO∙2SiO2 and comprising 38 wt.% apatite 
[Ca10(PO4)6(O, F2)], 24 wt.% wollastonite (CaSiO3) and 28 wt.% residual glassy phase. The 
glass-ceramic exhibits good bioactivity in vivo, and high mechanical strength (flexural strength: 
215 MPa and Young´s modulus: 118 GPa) [107]. Since 1983, this glass-ceramic has been used in 
spine and hip surgeries of patients with extensive lesions and bone defects [107]. It is due to 
these reasons that even after more than 3 decades of its discovery; CERABONE
®
 A-W glass-
ceramic still enjoys an immense attention from biomaterials community. However, despite all the 
salient features exhibited by this material, the scaffolds derived from this glass-ceramic still 
cannot be used in load-bearing applications [108]. Also, there are questions raised related to the 
long term effect of silica, and slow degradation of this glass-ceramic (apatite crystals have very 
high chemical durability)  [109], often taking some years to disappear from the body [110, 111]. 
The slow degradation of glass-ceramic scaffold may lead to reduction in its effective pore size by 
24 
 
in vivo events such as the invasion of fibrous tissue into the pores and the nonspecific adsorption 
of proteins onto the material’s surface. Therefore, there is an exigent need to design novel 
bioactive glasses with good sintering ability and optimized amorphous/crystalline ratio so as to 
achieve equilibrium between their mechanical properties, chemical degradation and bioactivity. 
 
2.5 Design of glass compositions for the present study 
 Diopside based 
materials have generated 
significant interest in 
biomedicine due to their 
good sintering behaviour 
resulting in mechanically 
strong ceramics/glass-
ceramics (diopside based 
glass-ceramics have 
higher mechanical 
strength than their 
wollastonite based 
analogues) [112, 113] with 
no general toxicity in cell cultures [114, 115] and ability to enhance bone regeneration [116-
118]. Further, incorporation of phosphate and fluoride component to these glass-ceramics will 
not only enhance their bioactivity (as discussed in section 2.3) but might also aid in sintering of 
diopside-rich glass-ceramics. Therefore, the parent series of glasses in this study has been 
designed along diopside (CaO•MgO•2SiO2) – fluorapatite (9CaO•3P2O5•CaF2) system.  
The phase equilibrium along diopside – fluorapatite join (Figure 2.5) has been studied by 
Tulyaganov [119, 120] and is characterized by the absence of any solid solutions. From the 
viewpoint of developing biomaterials, apatite-rich glass-ceramics were produced by controlled 
nucleation and crystallization along diopside – fluorapatite join by Hobo and Takoe with an 
objective of producing biomaterials for restorative dental applications under the commercial 
name of Cerapearl
®
 [107]. Special optical properties, such as high translucency, as well as 
excellent chemical resistance and strength, were required. These goals, however, were not 
Figure 2.5 Phase diagram of diopside – fluorapatite system 
[119] 
25 
 
always met and due to these reasons, this glass-ceramic was produced only for a limited time by 
Kyocera, Japan [107]. Few more attempts have been made to design diopside and fluorapatite 
containing bioactive glass-ceramics but mainly in ternary systems, for example, diopside – 
fluorapatite – mica [121] and diopside – Ca-Tschermak – fluorapatite system [122]. In nut-shell, 
despite being a potential system for developing fluoride-releasing bioactive glasses and glass-
ceramics (for scaffold fabrication), diopside – fluorapatite system has not been thoroughly 
studied for its structural, thermal and physico-chemical properties that could lead to development 
of 
biomaterials 
for bone 
tissue 
engineering. 
Therefore, we 
focused on 
understanding 
the 
connection 
between 
composition, 
molecular 
structure, 
sintering 
behaviour and 
bioactivity of 
these glasses. 
  
In the following set of glass compositions, we studied the influence of (i) Na2O/MgO and (ii) 
CaO/MgO ratios on the structure and sintering ability of bioactive glasses designed in the glass 
forming regions of diopside – fluorapatite – wollastonite system, as demonstrated in Figure 2.6. 
Alkali oxides (mainly Na2O and K2O), though non-essential, have become integral component of 
bioactive glasses owing to their ability to lower the glass melting temperatures and tailor their 
Figure 2.6 Glass compositions studied in CaO-MgO-P2O5-SiO2-CaF2 
system. Glasses were synthesized by melting the batch in Pt-Rh crucibles 
and quenching the melt in water. 
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chemical dissolution behaviour [8, 9, 12]. However, as discussed in section 2.3, fast dissolution 
behaviour [40] and poor sintering ability [41] of glasses with high alkali-content, for example: 
45S5 Bioglass
®
, renders them unfit for their aqueous processing and scaffold fabrication. 
Therefore, in order to design glasses with controlled dissolution behaviour, good sintering ability 
and minimal cytotoxicity in vitro, their alkali content needs to be well optimized. Thus, we 
focused on understanding the influence of alkali on chemical dissolution behaviour, thermal 
stability and bioactivity of these glasses.  
 Similarly as discussed in section 2.3, the influence of magnesium on structure and 
bioactivity of silicate/phosphosilicate glasses has been well discussed in literature. However, 
there is considerable dearth of literature on the influence of MgO on thermal properties of 
bioactive glasses. Therefore, a part of our work has been focused on elucidating the influence of 
CaO/MgO ratio on the sintering ability of bioactive glasses. 
On the basis of results obtained in our previous studies, we designed a final set of glass 
compositions in the primary crystallization field of diopside – fluorapatite – wollastonite, 
containing optimized concentrations of Na2O and MgO. The molecular structure and sintering 
ability of this series of glasses has been studied in the framework of this thesis while detailed 
bioactivity studies (in vitro, in vivo and human clinical trials) on a glass composition from our 
work have been reported elsewhere [123] and is out of scope of the present study. 
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Chapter 3. Experimental 
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3.1 Synthesis of glasses 
High purity powders of SiO2 (Alfa Aesar; 99%), CaCO3 (Alf Aesar, 99%), MgCO3 (Sigma 
Aldrich, purum p.a.), NH4H2PO4 (Alfa Aesar, 99%), Na2CO3 (Sigma Aldrich; 99%) and CaF2 
(99%, Alfa Aesar) were used. Homogeneous mixtures of batches (~100 g), in accordance with 
the designed compositions, obtained by ball milling, were calcined at 900 ºC for 1 h and then 
melted in Pt-Rh crucibles in temperature range 1500 – 1600 ºC for 1 h, in air. Glasses in bulk 
form were produced by pouring the melts on preheated bronze moulds following by annealing in 
temperature range 500 – 550 ºC for 1 h, depending on glass composition. The glasses in frit form 
were obtained by quenching of glass melts in cold water. The frits were dried and then milled in 
a high-speed agate mill resulting in glass powders with different particle sizes varying between 
10 – 225 μm (determined by light scattering technique; Coulter LS 230, UK; Fraunhofer optical 
model). The amorphous nature of glasses was confirmed by X-ray diffraction (XRD) analysis 
(Rigaku Geigerflex D/Max, Tokyo, Japan; C Series; Cu Kα radiation; 2θ angle range 10–80º; 
step 0.02º s
−1
).  
 
 
Figure 3.1 Schematic diagram showing the synthesis and processing of glasses 
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3.2 Structural characterization of glasses 
3.2.1 Infrared spectroscopy  
Infrared spectra of glass powders were obtained using a Fourier Transform Infrared 
Spectrometer (FT-IR, model Mattson Galaxy S-7000, USA). For this purpose each sample was 
mixed with KBr in the proportion of 1/150 (by weight) for 15 min and pressed into a pellet using 
a hand press. 
 
3.2.2 Magic angle spinning - Nuclear magnetic resonance (MAS-NMR) 
The 
29
Si MAS NMR spectra were recorded on a Bruker ASX 400 spectrometer operating 
at 79.52 MHz (9.4 T) using a 7 mm probe at a spinning rate of 5 kHz. The pulse length was 2 µs 
and 60 seconds delay time was used. Kaolinite was used as the chemical shift reference. The 
31
P 
MAS NMR spectra of glasses were recorded on a Bruker ASX 400 spectrometer operating at 
161.97 MHz with 45º pulses, spinning rates of 12 kHz, a 60 s recycle delay and the chemical 
shift was quoted in ppm from phosphoric acid (85%).  
 
3.3 Density measurements 
Archimedes’ method (i.e. immersion in diethyl phthalate) was employed to measure the 
apparent density of the bulk annealed glasses. Molar Volume (Vm), and excess volume (Ve) were 
calculated using the density data for the bulk glasses using following relations: 

M
Vm    
where M is the molar mass of the glass and is the apparent density of the bulk glasses. 
Similarly, excess volume of the glasses can be expressed as: 

i
mime iVxVV )(   (3.2), 
Here, xi is the molar concentration of every oxide and Vm(i) is the molar volume of every oxide.  
 
3.4 Thermal analysis 
3.4.1 Dilatometry 
Dilatometry measurements were done with prismatic samples with cross section of 4x5 
mm
2
 (Bahr Thermo Analyse DIL 801 L, Hüllhorst, Germany GmbH; heating rate 5 ºC min
1
). 
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The mean values and standard deviations (SD) presented for coefficient of thermal expansion 
(CTE), dilatometric glass transition temperature (Tdg), and softening temperature (Ts) have been 
obtained from (at least) three different samples.  
 
3.4.2 Differential thermal analysis (DTA) 
The crystallization kinetics of glass powders was studied using DTA (Labsys, Setaram, 
Caluire, France). 50 mg of glass powders were heated in ambient environment from room 
temperature up to 1000 ºC in alumina pans at heating rates () varying between 5 – 20 ºC 
min
1
.-alumina was used as a reference material. Glass transition temperature (Tg), 
temperature for onset of crystallization (Tc) and peak temperature of crystallization (Tp) were 
obtained from DTA thermographs.  
 
3.2.4.3 Hot-stage microscopy 
A side-view hot-stage microscope (HSM) EM 201 equipped with image analysis system 
and electrical furnace 1750/15 Leica was used. The microscope projects the image of the sample 
through a quartz window and onto the recording device. The computerized image analysis 
system automatically records and analyses the geometry changes of the sample during heating. 
The image analyser takes into account the thermal expansion of the alumina substrate while 
measuring the height of the sample during firing, with the base as a reference. The HSM 
software calculates the percentage of decrease in height, width and area of the sample images. 
The measurements were conducted in air with a heating rate of 5 ºC min
−1
. The cylindrical 
shaped samples with height and diameter of ≈3 mm were prepared by cold-pressing the glass 
powders. The cylindrical samples were placed on a 10×15×1 mm alumina (>99.5 wt.% Al2O3) 
support. The temperature was measured with a Pt/Rh (6/30) thermocouple contacted under the 
alumina support. The temperatures corresponding to the characteristic viscosity points (first 
shrinkage, maximum shrinkage, softening, half ball and flow) were obtained from the 
photographs taken during the hot-stage microscopy experiment following Scholze's definition 
[1]. 
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3.5 Synthesis of sintered glass-ceramics 
 Round shaped pellets with 20 mm diameter and ∼3 mm thickness were prepared from 
glass powder by uniaxial pressing (80 MPa). The samples were sintered under non-isothermal 
conditions (β = 5 ºC min−1) at 825 ºC or 850 ºC for 1 h in a box furnace in air. 
 
3.6 Characterization of glass-ceramics 
3.6.1 Crystalline phase analysis and microstructure 
The qualitative and quantitative analysis of crystalline phases in the glass–ceramics 
(crushed to particle size <63 μm) was made by XRD analysis using a conventional Bragg-
Brentano diffractometer (Philips PW 3710, Eindhoven, The Netherlands) with Ni-filtered Cu-Kα 
radiation. The quantitative phase analysis of the glass–ceramics was made by combined 
Rietveld-R.I.R (reference intensity ratio) method. A 10 wt.% of corundum (NIST SRM 676a) 
was added to all the glass–ceramic samples as an internal standard. The mixtures, ground in an 
agate mortar, were side loaded in aluminium flat holder in order to minimize the preferred 
orientation problems. Data were recorded in 2θ range = 5–115º (step size 0.02° and 50 s of 
counting time for each step). The phase fractions were extracted by Rietveld-R.I.R refinements 
using the software GSAS–EXPGUI and were rescaled on the basis of the absolute weight of 
corundum originally added to their mixtures as an internal standard, and therefore, internally 
renormalized. 
Microstructural observations were done on polished (mirror finishing) and chemically 
etched (by immersion in 2 vol.% HF solution for a duration of 2 min and washing with distilled 
water in order to stop the etching process and avoid the fluorides formation) glass–ceramics. The 
etched glass–ceramic samples were observed by scanning electron microscopy (SEM; SU-70, 
Hitachi) combined with energy dispersive spectroscopy (EDS; Bruker Quantax, Germany) to 
study the distribution of elements in the crystals. 
 
3.6.2 Linear shrinkage, density and mechanical strength 
Parallelopiped bars with dimensions of 4 mm × 5 mm × 50 mm were prepared from glass 
powders by uniaxial pressing (80 MPa). The samples were sintered under non-isothermal 
conditions (β = 5 ºC min−1) at 850 ºC for 1 h in a box furnace in air. The mechanical properties 
were evaluated by measuring the three-point bending strength of rectified parallelepiped bars of 
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sintered glass-ceramics (Shimadzu Autograph AG 25 TA; 0.5 mm min
−1
 displacement). The 
linear shrinkage during sintering was calculated from the difference of the dimensions between 
the green and the sintered bars. The mean values and the standard deviations (SD) presented for 
linear shrinkage, and bending strength have been obtained from (at least) 10 different samples. 
The mechanical reliability was tested by applying the well-known Weibull statistics to the 
bending strength data. According to Weibull statistics, the increasing probability of failure (F) 
for a brittle material can be expressed by F = 1 − exp(−σ/σ0)
m, where F is the failure probability 
for an applied stress (σ), σ0 is a normalizing parameter known as Weibull characteristic strength, 
and m is the Weibull modulus. Here, the Weibull modulus m is a measure of the degree of 
strength data dispersion.  
 
3.7 Chemical degradation and apatite forming ability 
The biodegradation and apatite forming ability of glasses and glass-ceramics in SBF was 
investigated by immersion of glass powders or sintered glass-ceramic circular discs (green 
diameter: 10 mm) in 50 ml SBF solution at 37 ºC. SBF had an ionic concentration (Na
+
 142.0, 
K
+
 5.0, Ca
2+
 2.5, Mg
2+
 1.5, Cl
−
 148.8, HPO4
−
 1.0, HCO3
2− 
4.2, SO4
2− 
0.5 mmol l
−1
) nearly 
equivalent to human plasma, as discussed by Tas [2]. The sample – SBF mixtures were 
immediately sealed into sterilized plastic flasks and were placed in an oven at 37 ºC (± 0.5 ºC) 
which was agitating in a circular motion at 120 rpm. The sampling took place at different times 
varying between 1 h and 28 days depending on the nature of samples (will be discussed in 
Chapter 4). Some experiments were performed in static mode (SBF was not replaced/refreshed) 
while SBF was completely replaced after every 48 h in other experiments. The experiments were 
performed in triplicate in order to ensure the accuracy of results. After each experiment, the 
solids and liquids were separated and pH along with their ionic concentrations [Ca
2+
, Mg
2+
, P
5+
, 
Si
4+
; inductively coupled plasma-optical emission spectroscopy (ICP-OES), Jobin Yvon, JY 70 
plus, France] were measured. The apatite forming ability on glass powders and glass-ceramics 
was followed by XRD, FTIR and SEM-EDS analysis.  
The degradation tests were performed according to the standard ISO 10993-14 
“Biological evaluation of medical devices – Part 14: Identification and quantification of 
degradation products from ceramics”. The test simulates the more frequently encountered in 
vivo pH (7.4 ± 0.1) and therefore investigates the degradation of glasses/ceramics in freshly 
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prepared Tris–HCl buffered solution. The glass powder with particle size varying between 300 
μm and 425 μm was added to the Tris–HCl solution in the powder/solution ratio of 0.05 g ml−1 (5 
g glass powder in 100 ml Tris–HCl solution). The tests were performed without solution 
replacement at 37 ºC and with a mixing speed of 120 rpm. The sampling was done after duration 
of 120 h where the solid and liquid phases were separated by filtering (0.22 μm, Millex GP, 
Millipore Corporation, U.S.A). The solid samples were then washed in deionised water and dried 
in an oven to constant weight. The pH along with elemental concentration, as measured by ICP-
OES or by atomic absorption spectroscopy (AAS), of the soaking solutions was measured. A 
relative weight loss percentage (WL) of glass samples after 120 h of immersion in solutions was 
calculated from the following equation: 
100
0
0 




 

W
WW
W tL , 
where W0 refers to the weight of glasses before immersion and Wt refers to the weight of glasses 
after immersion. The dried glass samples (after immersion) were analysed by XRD for possible 
occurrence of crystalline phases (if any).  
 
3.8 In vitro study on cell growth and osteogenic differentiation 
The biological performance of glasses and glass-ceramics was studied by the in vitro 
cellular responses, including cell proliferation and osteoblastic differentiation. Results were 
compared with the tissue culture plastic used as a control. For the cellular study, mesenchymal 
stem cells (MSCs) derived from rat bone marrow were used. MSCs have been a potential source 
for the regenerative therapy of tissues including bone, because of their multipotent and self-
renewal capacity without the concern of ethical issues. The experimental procedures were based 
on our previous work [3] and followed by the guidelines approved by the Animal Ethics 
Committee of Dankook University. MSCs gathered from the bone marrow of rats were 
maintained in a normal culture medium containing -minimal essential medium (MEM) 
supplemented with 10% foetal bovine serum (FBS), 100 U ml
−1
 penicillin and 100 mg ml
−1
 
streptomycin in a humidified atmosphere of 5% CO2 in air at 37 ºC.  
MSCs maintained up to 34 passages were used for cellular study. The glass-ceramics 
were sterilized with 70% ethanol for 1 h prior to seeding cells. For the cell growth study, MSCs 
were seeded on each sample (15 mm x 2 mm disc type) and then cultured in the normal culture 
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medium condition as described above. After culture for 3, 7 and 14 days, the cell growth level 
was analyzed by the (3-(4,5-dimethylthiazol-2-yl)-5(3-carboxymethonyphenol)-2-(4-
sulfophenyl)-2H-tetrazolium) (MTS) assay. At each culture time, the culture medium was 
decanted and the CellTitero 96 AQueous One Solution Reagent (Promega) was added to each 
sample and then reacted at 37 ºC for 3 h. The absorbance at 490 nm was read using an Elisa Plate 
Reader (Lab systems Inc.). The cell growth morphology was observed by SEM (Hitachi) after 
fixation the cells with 2.5% glutaraldehyde, dehydration with a graded series of ethanol (50, 70, 
90 and 100%) and coating with gold.  
The osteoblast differentiation of the MSCs on the glass-ceramics was determined by 
measuring the alkaline phosphatise (ALP) activity. Cells were seeded on each sample (20 mm x 
2 mm disc type), and cultured in the osteogenic medium containing 50 μg ml1 sodium ascorbate, 
10 mM β-glycerol phosphate, and 10 nM dexamethasone. After culture for 7 and 14 days, 
cellular samples were gathered and added to the ALP reaction media to allow an enzymatic 
reaction according to the manufacturer’s instruction (Sigma). The quantity of samples used for 
the reaction was determined based on the total protein content which was determined by using a 
commercial DC protein assay kit (BioRad).  
The MTS and ALP assays were performed on three replicate samples (n = 3). Data were 
represented as means ± standard deviations. Statistical analysis was carried out by analysis of 
variance (ANOVA) and significance level was considered at p < 0.05.  
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Section 4.1 
Understanding the molecular structure, sintering ability and 
bioactivity of glasses along diopside – fluorapatite join 
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1. Glass forming ability 
A series of glass compositions in the system (CaMgSi2O6)(100-x)  - [Ca5(PO4)3F]x (x = 0 – 
50 wt%) have been prepared in Pt-Rh crucibles at 1590 ºC by melt-quenching technique. The 
glass compositions have been labelled in accordance with their fluorapatite (hereafter referred as 
FA) content. For example, FA-0 corresponds to x = 0, FA-10 corresponds to x = 10, etc. Table 
4.1 presents the detailed compositions of glasses investigated in the present study. 
 
Table 4.1 Chemical composition of glasses  
Glass  MgO CaO SiO2 P2O5 CaF2 
FA-0 mol% 25.00 25.00 50.00 - - 
 wt% 18.61 25.90 55.49 - - 
FA-10 mol% 23.20 28.19 46.40 1.66 0.55 
 wt. 16.75 28.31 49.94 4.22 0.77 
FA-20 mol% 21.29 31.58 42.57 3.43 1.14 
 wt% 14.89 30.73 44.39 8.44 1.55 
FA-25 mol% 20.28 33.34 40.56 4.36 1.46 
 wt% 13.96 31.93 41.62 10.56 1.94 
FA-30 mol% 19.25 35.18 38.48 5.31 1.77 
 wt% 13.03 33.14 38.84 12.67 2.32 
FA-35 mol% 18.17 37.08 36.34 6.30 2.10 
 wt% 12.10 34.34 36.07 14.78 2.71 
FA-40 mol% 17.07 39.04 34.12 7.33 2.45 
 wt% 11.17 35.55 33.29 16.89 3.10 
FA-50 mol% 14.73 43.18 29.45 9.48 3.16 
 wt% 9.31 37.97 27.75 21.11 3.87 
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Figure 4.1 SEM images of crystallized glass surface: (a) FA-35, and (b) FA-40. Fluorapatite 
phase crystallized on the surface of both the glasses immediately after pouring the glass melt on 
metallic mould. 
Among all the investigated compositions, we could obtain amorphous monolithic glasses 
(by pouring glass melt on metallic mould) only for compositions with x = 10 - 30 wt% while 
glasses in frit form (by quenching glass melt in cold water) were obtained for compositions with 
x ≤ 40 wt%. The monolithic glass rods as obtained for compositions FA-0, FA-35 and FA-40 
exhibited severe tendency towards surface devitrification, thus, resulting in the formation of 
diopside crystals in composition FA-0 and FA crystals for FA-35 (needle-like) and FA-40 
(rosette morphology) as depicted in Figure 4.1. The difference in morphology of fluorapatite 
crystals observed on the surface of these glasses may be attributed to the liquid-liquid phase 
separation commonly observed in SiO2 and P2O5-containing glasses [1, 2]. Phase separation 
processes have been shown to have a major impact on the structure and chemistry of parent 
glasses which in turn determine the fluorapatite morphology observed [1]. Similar observations 
regarding morphology of fluorapatite crystals in glass-ceramics (needle vs. spherical) have been 
reported by Hoche et al. [1] in glass system SiO2-Al2O3-CaO-P2O5-K2O-F. 
The melting of compositions with x > 40 wt% at 1590 ºC for 2 h resulted in highly 
viscous liquid which was prone to spontaneous crystallization even after quenching in cold water 
resulting in white, opaque material with FA as the only crystalline phase, as revealed by XRD 
analysis. This was expected considering almost equal concentrations of SiO2 and P2O5 leading to 
immiscibility between silicate and phosphate-rich phases. Further, increasing FA content in 
glasses will shift the liquidus temperature of the overall system towards higher side (liquidus 
temperature of stoichiometric fluorapatite is 1630 ºC while that for stoichiometric diopside is 
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1392 ºC) [3]. Therefore, higher melting temperatures and faster quenching rates are required to 
obtain glasses from compositions with x > 40 wt%. Thus, the present study is dedicated towards 
the understanding the molecular structure, sintering and crystallization kinetics, and bioactivity 
of glasses along diopside- fluorapatite system where FA content varies between 0 – 40 wt%. 
 
2. Structure of glasses  
The broad 
29
Si MAS-NMR spectra for all the investigated glasses (Figure 4.2a) implies 
towards a wider distribution of Q
n
 (Si) species in 
the glass structure with dominance of Q
2
 (Si) 
structural units. [4]. No significant shifts were 
observed in the peak position of 
29
Si NMR spectra 
of glasses with varying diopside/fluorapatite ratio. 
Although it is difficult to provide a concrete 
explanation for this observation owing to the 
complex chemistry of the glass system, the 
possible reason may be attributed to the significant 
increase in CaO concentration in glasses (25 mol% 
for FA-0 and ~39 mol% for FA-40) in comparison 
to P2O5 (varies between 0 – 7 mol%). The higher 
concentration of network modifying cations and 
decrease in SiO2 content (50 mol% for FA-0 and 
~34 mol% for FA-40) in glasses possibly negated 
the re-polymerization effect induced by P2O5. It 
has been reported that in a stoichiometric diopside 
glass (FA-0 in the present case), the distribution of 
Q
n
 (Si) is: 28% Q
1
, 43% Q
2
, 25% Q
3
 and 4% Q
4
 
[5]. This distribution of Q
n
 (Si) species in FA-0 
glass is quite close to the Q
n
 (Si) distribution of the 45S5 glass (15% Q
1
, 67% Q
2
, 18% Q
3
) 
calculated by Linati et al. [6], since a mixture of (Q
1
 + Q
2
) units predominate in both cases, thus 
giving an indication  of good bioactivity. These results are in good agreement with recently 
published studies by Goel et al. [7] and Kapoor et al. [8] on similar glass compositions where the 
FA-0
FA-10
FA-20
FA-25
FA-30
FA-35
FA-40
-81 ppm
-150-100-500
29
Si Chemical shift (ppm)(a)
FA-10
FA-20
FA-25
FA-30
FA-35
FA-40
1.91 ppm
-30-101030
31
P Chemical shift (ppm)(b)
Figure 4.2 (a) 
29
Si MAS NMR spectra 
and (b) 
31
P MAS NMR spectra of 
investigated glasses. 
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NC values for these glasses, as calculated using MD simulations, have been obtained to be 
varying between 1.95 – 2.0. 
The 
31
P MAS-NMR spectra of all the glasses show a predominance of an 
orthophosphate-type environment (Figure 4.2b). In fact, the observed chemical shifts, 1–3 ppm, 
are close to that of the calcium orthophosphate (3.1 ppm) and that of the amorphous magnesium 
orthophosphate (ca. 0.5 ppm) [9]. These results are in good co-relation with those reported by 
Lusvardi et al. [10] and Linati et al. [6] for the 45S5 glass where it has been deduced a fraction of 
orthophosphate units of ~82% while the rest might be comprised of meta- or pyrophosphates. 
Furthermore, the introduction of fluoride ion in the phospho-silicate glass network is known to 
induce significant changes in the local oxygen environment. As has been discussed in Chapter 2, 
the possibility of Si–F bond formation in bioactive glasses is unlikely. In bioactive glasses, 
fluoride remains predominantly in ionic state and prefers to form ionic bonds with 
alkali/alkaline-earth cations (preferably with calcium [7, 8]), thus avoiding the de-polymerization 
of silicate glass network and forcing phosphate groups to link with silicate groups, leading to 
higher glass connectivity [10]. However, considering the small concentration of fluoride 
incorporated in the glass batch (0 – 2.45 mol%) and possibility of significant fluoride 
volatilization during glass melting [11], the feasibility of the formation of SiOP bonds is low 
if not negligible (as depicted by insignificant shift in 
29
Si and 
31
P NMR spectra). In fact, 
according to the NMR results, phosphate groups are not part of the actual glass network 
backbone. Similar results have also been obtained by Brauer et al. [4] on a series of SiO2-P2O5-
CaO-Na2O-CaF2 glasses where it was found that addition of CaF2 did not disrupt the network 
connectivity by forming Si–F bonds, instead, formed mixed calcium sodium fluoride species. 
 
3. Glass transition and thermal expansion behaviour 
As is evident from Figure 4.3, Tg of the glasses decreased while CTE increased with 
increase in FA content. It should be noted that since monolithic glass of composition FA-0 was 
prone to surface crystallization, we could not obtain experimental CTE value for this 
composition. Therefore, CTE value for glass FA-0 has been obtained from literature to be 8 x 10
-
6
 K
-1
 [12]. The decrease in Tg can be explained by the decreasing concentration of silica, 
increasing network modifier content (CaO), and the low fraction of Si-O-P linkages as has been 
explained above. Additionally, with addition of CaF2 in glasses, fluoride is complexing with 
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calcium or magnesium, thus, 
hypothetical CaF
+
 and MgF
+
 
species are added to the 
silicate ions which reduce the 
electrostatic forces between 
NBOs considerably [7], thus 
decreasing the Tg and 
increasing CTE of glasses. 
 
4. Sintering behaviour of 
glass powders 
Figure 4.4 presents 
the data as obtained from 
DTA and HSM ( =5 K min-
1
) pertaining to sintering and 
devitrification behaviour of 
glass powders (particle size 
varying between 10 – 15 m) that allows observing the following trends: 
i) Figure 4.4(a-c) presents the variation in the relative area obtained from the HSM 
measurement and heat flow with respect to temperature for glass FA-0 (Figure 4.4a), FA-
20 (Figure 4.4b) and FA-35 (Figure 4.4c), respectively. The DTA thermographs of 
glasses with FA content varying between 0-30 wt% exhibited a single crystallization 
exothermic curve as presented in Figure 4.4a and Figure 4.4b. This signifies that the 
glass-ceramic is formed either as a result of single phase crystallization or of an almost 
simultaneous precipitation of two or more crystalline phases. Further, two well defined 
crystallization exotherms could be observed from DTA thermographs for glasses FA-35 
(Figure 4.4c) and FA-40 (not shown) implying towards the precipitation of at least two 
different crystalline phases. Similar trends were observed for respective glasses at 
different heating rates.  
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Figure 4.3 Plot depicting variation in glass transition 
temperature (Tg) and coefficient of thermal expansion 
(CTE) with respect to fluorapatite content in glasses. 
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Figure 4.4 Comparison of DTA and HSM curves on the same temperature scale for glasses (a) 
FA-0, (b) FA-20, (c) FA-35 at heating rate of 5 K min
-1
. Figure 4.4(d) presents the variation in 
different thermal parameters for glasses obtained from DTA and HSM, respectively with respect 
to fluorapatite content in glasses. 
 
ii) The temperature of first shrinkage (TFS; log = 9.1 ± 0.1, is viscosity; dPa s) (Figure 
4.4a) showed a slight decrease with increasing FA content in glasses (Figure 4.4d). 
iii) A single stage shrinkage behaviour was observed for glass FA-0 with its temperature of 
maximum shrinkage (TMS; log = 7.8 ± 0.1) coinciding with its onset of crystallization 
(Tc) (Figure 4.4a), thus leading to value of sintering ability, Sc (Tc – TMS) = 0 as has been 
shown in Figure 4.4d. The low value of sintering ability (Sc) implies towards poor 
TMS
HSM TFS
Tp
TcDTA
0.6
0.7
0.8
0.9
1
1.1
600 700 800 900 1000
Temperature (
o
C)
A
re
a 
(A
/A
o
)
D
T
 (

V
)
FA-0  = 5 K min
-
1
Exo
(a)
HSM
TFS
TMS1
TMS2
DTA
0.5
0.6
0.7
0.8
0.9
1
1.1
600 700 800 900 1000
Temperature (
o
C)
A
re
a 
(A
/A
o
)
D
T
 (

V
)
FA-20
(b)
HSM
DTA
Tp2
Tp1
0.5
0.6
0.7
0.8
0.9
1
1.1
600 700 800 900 1000
Temperature (
o
C)
A
/A
o
D
T
 (

V
)
FA-35
 = 5 K min
-
1
Exo
(c)
Tp1 Tp2
Tc
TFS
TMS
Sc
700
750
800
850
900
950
1000
0 10 20 30 40
FA (wt.%)
T
em
p
er
at
u
re
 (
o
C
)
0
20
40
60
S
c 
=
 T
c 
- 
T
M
S
 (
o
C
)
(d)
63 
 
densification [13]. However, since, maximum densification was achieved exactly at the 
onset of crystallization (i.e. crystallization did not start before maximum densification 
could be achieved), therefore, well sintered glass powder compact but with high amount 
of crystallinity (as will be shown in next section) was obtained after heat treatment at 850 
o
C for 1 h.  
iv) The introduction of FA in glasses (FA-10) enhanced the sintering ability of glass system 
considerably by inducing a two-stage shrinkage as has been shown in Figure 4.4b (for 
glass FA-20), thus leading to a significant difference between Tc and TMS (TMS1 for glass 
FA-10), resulting in a higher value of Sc (Figure 4.4d). Similar two-stage shrinkage 
behaviour was observed for all the FA containing glasses and can be attributed to the 
presence of glass-in-glass phase separation in the parent glasses due to the presence of 
silicate and phosphate rich phases.  
v) As is evident from Figure 4.4d, the value of sintering ability parameter (Sc) increased 
with increase in FA content until glass FA-25 while further increase in FA content in 
glasses led to degradation of sintering ability. In agreement with the HSM and DTA 
results, well sintered and dense glass powder compacts were obtained for compositions 
with 10 ≤ FA ≤ 25 wt% while glass-ceramic from composition FA-40 was highly porous 
and mechanically weak. 
 
5. Crystalline phase evolution in sintered glass-ceramics 
  Figure 4.5a presents the X-ray diffractograms of glass powder compacts depicting their 
crystalline phase assemblage after sintering at 850 ºC for 1 h. Diopside (CaMgSi2O6; ICDD card: 
01-078-1390) crystallized as the only phase in compositions FA-0 and FA-10 while further 
increase in FA/Di ratio led to the precipitation of both diopside as well as fluorapatite. The 
quantitative crystalline phase analysis of investigated glass-ceramics as presented in Figure 4.5b 
exhibits that glass FA-0 showed an extensive crystallization with ~2 wt% of residual glassy 
phase. This result is in good agreement with the microstructure of glass-ceramic FA-0 as 
presented in Figure 4.6a, where it is difficult to observe any amorphous phase in the sintered 
glass powder compact. Under such circumstances, we cannot possibly expect good bioactivity 
from this composition. However, introduction of fluorapatite in diopside glass system 
significantly influenced its crystallization tendency with the residual glassy phase increasing 
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from ~2 wt% (for glass FA-0) to ~72 wt% for glass FA-10 (Figure 4.5b and Figure 4.6b). At this 
juncture, we would like to mention that it was not possible to calculate the amount of crystalline 
and amorphous phase in GC FA-20 from Rietveld-refinement technique, possibly due to very 
high amount of residual amorphous phase as can be judged from very low peak intensity of X-
ray diffractograms presented in Figure 4.5a. 
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Figure 4.5 (a) X-ray diffractograms of glass-powder compacts sintered at 850 
o
C for 1 h, (b) 
quantitative crystalline phase analysis of glass-ceramics with respect to fluorapatite content in 
glasses as obtained from Rietveld-R.I.R. technique. (c) Observed (crosses), calculated 
(continuous line), and difference curve from the Rietveld refinement of the glass-ceramic FA-
35. Markers representing the phase reflections correspond to corundum, fluorapatite, and 
diopside (from top to bottom). 
(c) 
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Figure 4.6 SEM images of glass-ceramics (a) FA-0, (b) FA-10, (c) FA-25, and (d) FA-40 after 
sintering of glass powder compacts at 850 
o
C for 1 h. 
 
 
Therefore, we expect that the amorphous phase in composition FA-20 is higher (> 72 wt%) in 
comparison to FA-10. Further increase in fluorapatite content (> 20 wt%) increased the 
crystalline/amorphous ratio in glass-ceramics (as is also evident from the SEM images presented 
in Figure 4.6c and 4.6d) with fluorapatite (ICDD card: 04-008-0676) emerging as dominant 
crystalline phase in composition FA-40. Figure 4.5c shows the fit of a measured XRD pattern of 
glass-ceramic FA-35 by using the GSAS-EXPGUI software. The difference plot does not show 
any significant misfits. The differences under the main peaks of diopside, fluorapatite, and 
corundum (internal standard) are caused by adjustment difficulties based on crystallinity of 
phases.    
 
 
 
(a) (b) 
(c) (d) 
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6. Biodegradation of glasses in simulated body fluid (SBF) 
 The surface reactivity of glasses was investigated by immersion of glass powders in SBF 
(0.25 g glass powder in 50 ml SBF solution) at 37 ºC. 45S5 Bioglass
®
 was used as a reference 
material.  
 Figure 4.7 ICP plots of elemental concentration of (a) Ca, (b) P, (c) Mg, (d) Si, in SBF solution 
versus immersion time for the investigated glasses. 
 
6.1 Elemental release profile of glasses in SBF 
Figure 4.7 presents the trends observed for elemental release profile of glasses in SBF 
solution. The following observations have been made: 
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i)  The trend of calcium concentration after 6 h of immersion corresponds to an increase 
for all glasses which reaches its maximum within 1-24 h of immersion (Figure 4.7a). 
The increasing Ca concentration in SBF during 1-24 h of immersion for all glasses 
corresponds to the forward dissolution rate of glasses and imply towards the initiation 
of bio-mineralization process, where modifier cations in the glass exchange with 
hydronium ions in the external solution [14]. A decrease in calcium concentration in 
SBF with increasing immersion time is due to the solution feedback effect that will 
lead to the formation of calcium-containing compounds on the glass surface, for 
example: carbonated-hydroxyapatite (HA) or calcite (CaCO3). After ~100 h of 
immersion time in SBF, calcium concentration reached a plateau exhibiting 
equilibrium between glass and contact solution.  
ii) The trend of overall phosphate concentration demonstrates a slowly decreasing value 
as a function of soaking time (Figure 4.7b) which is due to migration of phosphorus 
ions to glass surface to form calcium phosphate rich layer [15]. Increasing FA content 
in glasses led to increasing concentration of phosphorus-ions in SBF as is evident 
from Figure 4.7b which may be attributed to either the release of additional soluble 
phosphate species or fast hydrolysis of small amounts of labile P-O-Si bridges from 
the glasses in fluid which might lead to local super-saturation and accelerate the 
calcium phosphate precipitation from solution. 
iii) The Mg concentration exhibited behaviour similar to that of Ca in SBF solution and 
was detected to be highest after 24 h of immersion time for all the glass compositions 
while no significant variations were observed after prolonged SBF immersions 
(Figure 4.7c) possibly due to attainment of equilibrium between the Mg
2+
 
concentration in glass and SBF, respectively. In general, the amount of Mg detected 
in SBF solution after any particular immersion time was highest for glass FA-0 and it 
decreased with decreasing Di/FA ratio. This behaviour can be attributed to the 
decreasing Mg concentration in the glasses due to increasing FA/Di ratio.  
iv) Among all the investigated glasses, the Si ion concentration in SBF was highest after 
7 days for glasses FA-0 and FA-40 (Figure 4.7d). However after 14 days (336 h), 
glasses FA-10 and FA-20 presented higher Si leaching rates, thus indicating a higher 
ability to form apatite. The loss of silica species from glass indirectly enhances the 
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bioactive behaviour through the surface SiOH groups generated in the SiOSi 
hydrolysis process which in turn decrease the interface energy between apatite and 
glasses [16]. It has been shown that silica gel induces apatite formation on its surface 
in simulated body environment while silica glass and quartz do not induce it in the 
same environment [16]. 
 
 
 
 
 
6.2 pH evolution in SBF 
The trend of pH evolution after dissolution of investigated glasses in SBF solution for 
time duration varying between 1 h – 28 days is presented in Figure 4.8 and described below:  
i) The pH values observed during dissolution of the 45S5 glass in SBF correspond to a 
gradual increase from 7.45 to 9.96 during the first 21 days of immersion time, 
reaching a plateau for ~ 500 h of immersion time. The pH maximum reached by the 
whole series of Di-FA glasses is definitely lower than the one obtained for the 45S5 
glass. 
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Figure 4.8 The plots depicting pH of SBF solution as a function of 
immersion time duration for the investigated glasses. 
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ii) In the case of glass FA-0, the pH values increased until 7 days of glass immersion in 
SBF, reaching a pH maximum of 9.04, which remained almost constant for higher 
immersion times. 
iii) The pH values of SBF solutions with FA containing glasses were higher during the 
initial 3 h of immersion, in comparison to glass FA-0. However, with further increase 
in immersion time, the pH value of the SBF solution containing glass FA-0 surpassed 
the values of SBF solutions with FA containing glasses. This increase in pH during 
initial hours of dissolution may be attributed to the excess leaching of alkaline earth 
cations from phosphate and fluoride component of glasses in SBF solution, as has 
also been confirmed by ICP-OES results (Fig. 4.7).   
In general, pH > 8 was achieved for all the glasses after immersion in SBF for 3 h and the pH 
of all solutions remained higher than 8.5 for the longest exposure times. It has been reported that, 
in case of 45S5 glass, the total reconstruction of glass occurs at pH = 8. At pH > 8, calcium 
phosphate precipitation occurs immediately after immersion, thus preventing any further large 
ion release and favouring the formation of CaCO3 in comparison to HA [17]. Similar results have 
been obtained, in the present study, which will be discussed in the following sections. It is 
noteworthy that antibacterial properties of bioactive glasses are based on their potential to raise 
the pH in aqueous suspensions [18], resulting from the exchange of modifier cations from glass 
matrix with hydronium ions from aqueous environment. Bioactive glasses, however not only 
dissolve or release calcium; they can also release silica, phosphate and sodium. This ion release 
promotes an additional indirect pH-related antibacterial effect [19]. 
6.3 FTIR and XRD analysis 
The XRD patterns observed for all as-quenched parent glasses (not shown) are in good 
agreement with their FTIR spectra (Figure 4.9a), exhibiting a broad amorphous halo. The FTIR 
spectra of 45S5 Bioglass
®
 has been taken as a reference in order to make its structural 
comparison with the glasses under investigation. As evident from Figure 4.9a, despite significant 
differences in the chemical composition of the investigated glasses in comparison to the 
composition of 45S5 Bioglass
®
, the structure of all the glasses is almost similar to that of 45S5 
glass. The infra-red spectra of all the investigated glasses exhibit three broad transmittance bands 
in the region of 3001300 cm1. This lack of sharp features is indicative of the general disorder 
in the silicate and phosphate network mainly due to a wide distribution of Q
n
 units occurring in  
70 
 
 
Figure 4.9 FTIR spectra of: (a) glasses before immersion in SBF, (b) glasses after immersion in 
SBF for 1 h, (c) 45S5 Bioglass after immersion in SBF for different time durations, (d) glasses 
after immersion in SBF for 3 h 
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these glasses. The most intense bands in the 8001300 cm1 region correspond to the stretching 
vibrations of the SiO4 tetrahedron with a different number of bridging oxygen atoms [20]. In case 
of glass FA-0, this region (i.e. 8001300 cm1) is further split in two transmittance bands centred 
at ~1022 cm
1
 and ~940 cm
1
. The high frequency band can be assigned to the Si-O asymmetric 
stretching mode of BOs, whereas the ~940 cm
-1
 may be attributed to the Si-O asymmetric 
stretching mode of the non-bridging oxygens (NBOs) [21, 22]. Further, the 498 cm
-1
 band can be 
attributed to Si-O-Si bending modes [22], while the weak 750 cm
-1
 shoulder may be due to Si–
O–Si symmetric stretching with simultaneous Si cation motions [23]. The systematic substitution 
of diopside by fluorapatite led to a gradual shift of the 1022 cm
-1
 and 498 cm
1
 bands (in glass 
FA-0) to 1039 cm
1 
and 505 cm
1
 (in glass FA-40), respectively, while the bands at ~940 cm
1 
and the ~750 cm
-1 
remain unchanged. In glasses with higher FA content (i.e. FA-35 and FA-40), 
a shoulder was observed at ~560 cm
-1
, which is due to the bending modes of the PO4 unit [24]. It 
is noteworthy that the high frequency band at 1039 cm
-1
 may also be assigned to the asymmetric 
stretching of PO4 units which has been reported to appear in crystalline FA at 1038 cm
-1
 [24]. 
 After immersion in SBF for 1 h, FTIR spectra of all the glasses (including the 45S5 glass) 
showed considerable differences in comparison to the spectra of their respective parent glasses as 
shown in Figure 4.9b. A strong low frequency band centred at ~470 cm
-1
, ascribed to the 
deformation mode of silica layer that develops on the dissolving glass particles [25] could be 
seen in all the glasses. The main IR band now occurs at 1070 cm
-1
 and a nearby shoulder, centred 
at ~1225 cm
-1
 and attributed to Si-O-Si vibration [17], can be observed in all the glasses, due to 
the interfacial formation of high-area silica gel layer, as postulated in Hench’s inorganic reaction 
set [26]. Further, twin peaks at ~ 1420 cm
-1
 and ~ 1500 cm
-1
, corresponding to the formation of 
complex carbonate species connected with the presence of Ca
2+
 ions in the surface [25], appear 
in all the glasses. Also, two sharp peaks at ~715 cm
-1
 and 875 cm
-1
, indicative of the interfacial 
precipitation of a crystalline carbonate species, i.e. calcite (CaCO3) (as confirmed by XRD, 
Figure 4.10a), could be observed in glasses 45S5 and FA-0, respectively. These two peaks were 
absent in all the FA containing glasses signifying a lower tendency of FA containing glasses 
towards calcite formation, as confirmed by XRD (Fig. 4.10a). These results are in good 
agreement with the ICP-OES results, where it has been depicted that Ca ion concentration in 
SBF solution decreased with increasing FA content. Therefore, lower amount of Ca is available 
for precipitation of carbonate species. Furthermore, two small sharp peaks were observed in the
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45S5 glass at ~565 cm
1
 and 610 cm
1
. This is the most characteristic region for apatite and other 
phosphates as it corresponds to P-O bending vibrations in a PO4
3-
 tetrahedron and indicates the 
presence of crystalline calcium phosphates including HA. A single peak in this region suggests 
the presence of non-apatitic or amorphous calcium phosphate, which is usually taken as an 
indication of presence of precursors to HA. Apatitic PO4
3-
 groups have characteristic split bands 
at ~560 and 600 cm
1
, with a third signal at ~575 cm
1
 observed for crystallites of small size [25, 
27]. No such bands could be observed in glasses FA-0 and FA-10, thus exhibiting no Ca-
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Figure 4.10 (a) XRD patterns of glasses after immersion in SBF solution for 1 h; (b) Plot 
depicting the change in peak intensities of XRD phase reflections of calcite (C) and 
hydroxyapatite (HA) for 45S5 Bioglass as a function of immersion time in SBF solution; 
(c) XRD pattern of glasses after immersion in SBF for 28 days. 
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phosphate formation. These results are in complete agreement with XRD data of glasses as 
presented in Figure 4.10a. However, with increment in FA content (≥20 wt%) in glasses, a band 
at 565 cm
1
 could be observed which increased in intensity with increasing FA content, thus 
indicating towards rapid formation of amorphous Ca-phosphate layer on glass [25]. The 
increasing tendency towards development of amorphous Ca-phosphate rich layer with increasing 
FA content in glasses may be explained on the basis of increasing phosphate concentration and 
decreasing Mg concentration in glasses. It has been reported in literature that Mg tends to 
associate preferentially with phosphorus at glass surface, which consequently leads to the 
decrease in concentration of apatite like-calcium phosphate domains on the glass surface that are 
supposed to act as nucleation centres for apatite formation [28]. Also, glass compositions 
containing phosphate are known to be more soluble and exhibit faster release of silica in 
solution. Further, isolated orthophosphate groups can be directly released without breaking any 
chemical bond; thus high rate of formation of amorphous calcium phosphate rich layer in FA 
containing glasses is likely related to the high availability of this species [15]. An increase in 
immersion time of glasses in SBF solution for 3 h led to disappearance of the bands at ~565 cm
1
 
and 610 cm
1
 bands, in the 45S5 glass IR spectrum (Figure 4.9c) implying towards dissolution of 
crystalline Ca-phosphate while the bands pertaining to the formation of complex carbonates 
(~1430, 1485 cm
1
), crystalline carbonates (~875 cm
1
) and high- silica gel layer (~1225 cm
1
) 
became more evident. FTIR data is supported by XRD results presented in Table 4.2, where it is 
clear that calcite formation masked the precipitation of crystalline apatite in all the glasses 
including 45S5 glass (Figure 4.10b). However, as revealed by the intensity of XRD phase 
reflections corresponding to calcite (Figure 4.10a and 4.10c), it is evident that increasing fluoride 
content in glasses decreased the tendency of calcite formation in glasses. With SBF immersion 
time of 7 days, the twin peaks at ~565 cm
1
 and 610 cm
1
 appeared again for the 45S5 glass, 
while all the investigated glasses including glass FA-0 exhibited only the formation of 
amorphous calcium phosphate layer as observed in Figure 4.9d. According to XRD results, 
precipitation of calcite was favoured in comparison to HA, in all the glasses, as the intensities of 
peak reflections corresponding to HA be considerably lower than the calcite peak intensities, as 
presented in Figure 4.10. HA formation was favoured mainly in the FA-40 glass after 28 days of 
immersion time in SBF (Table 4.2, Figure 4.10c). It is noteworthy that Ca-carbonate phases 
present a higher solubility product (Kps calcite = 1.7 × 10
−8
) with respect to HA 
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Table 4.2 Crystalline phase evolution on glass surface after immersion of glasses in SBF solution for varying time durations.  
(C: Calcite; A: Aragonite; HA: Hydroxyapatite) 
 Glass labels 
 45S5 FA-0 FA-10 FA-20 FA-25 FA-30 FA-35 FA-40 
1 h C; HA  C; A C; A C C C C Amorphous 
3 h C  C C; A Amorphous Amorphous Amorphous Amorphous Amorphous 
6 h C  C A Amorphous Amorphous Amorphous Amorphous Amorphous 
12 h C  Amorphous C; A Amorphous Amorphous HA Amorphous Amorphous 
1 day C  C Amorphous Amorphous Amorphous HA Amorphous Amorphous 
3 days C; HA C A Amorphous Amorphous Amorphous Amorphous Amorphous 
7 days C; HA C A Amorphous Amorphous Amorphous Amorphous Amorphous 
14 days C; HA C A C Amorphous Amorphous Amorphous C 
21 days C; HA C C; HA A Amorphous Amorphous Amorphous C; HA 
28 days C; HA C Amorphous C Amorphous Amorphous Amorphous HA 
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(Kps HA = 1.6 × 10
−58
) at pH 7.4 [25], and this should favour the precipitation of latter, but Ca-
carbonate phases are likely to present a higher rate of crystallization because of the presence of 
basic surface species (for instance: O
2
 ions, OH

 ions or coordinatively unsaturated cation-anion 
pairs), which can coordinate with CO2, thus giving rise to many possible types of carbonate like 
species. According to Cerruti and Morterra [17], the carbonate formation in silica-based 
bioactive glasses occur only if both CO2 and an excess of water are present at the same time as it 
is believed that the gas-phase admission of both CO2 and an excess of water mimics the long-
lasting process of carbonate formation. According to Jones et al. [14], the crystallization 
mechanism of calcite at the expense of HA during in vitro bioactivity analysis of glasses in SBF 
is dose dependant and in case of 45S5 glass, calcite formation is favoured at the expense of HA 
when the concentration of glass to SBF solution exceeds 0.002 g ml
1
 (0.005 g ml
1 
in present 
study) due to an increase in the ratio of Ca/P ions, in solution. At high concentrations, when there 
are excessive Ca ions in solution causing an increase in pH of the solution, CaCO3 forms at the 
expense of HA formation. 
 
7. Physico-chemical degradation of glasses in Tris-HCl buffer  
One of the relevant parameters in the study of glass dissolution is the kind of medium 
used. The pH and ionic strength of the medium play an important role in the rate at which the 
glasses dissolve. The variation in pH of Tris–HCl with respect to FA content in glasses is 
presented in Figure 4.11a. A slight increase in pH from 7.4 to 8.41 was observed with increasing 
FA content in glasses while highest pH value of 9.68 was observed for the 45S5 glass, which 
exhibited higher dissolution rate than the investigated glasses. This steep pH increase for 45S5 
Bioglass may be attributed to the preferential release of sodium over calcium from this glass as 
has been computationally predicted by Tilocca [29] and experimentally reported by us [30]. It is 
due to this reason that glass 45S5 exhibited the highest weight loss in Tris-HCl among all the 
investigated glasses (Figure 4.11c). The increasing pH of buffer solution with increasing FA 
content in glasses may be attributed to the increasing dissolution of Ca and Mg ions from glasses 
due to dissolution of charged ion pairs (Ca-F)
+
 or (Mg-F)
+
 along with the partial disruption of 
silicate glass network as depicted by the ICP-OES results presented in Figure 4.11b. According 
to recent studies by Goel et al. [7] and Kapoor et al. [8], fluoride as well as phosphate component 
in alkali-free bioactive glasses tends to associate preferentially with calcium in comparison to 
76 
 
magnesium. Therefore, higher release of calcium is expected from glass compositions 
comprising equimolar concentration of two cations. The weight loss increased with increasing 
FA content in glasses (Figure 4.11c), the highest weight loss of ~1 wt% was observed for glass 
FA-40. The FTIR spectra of the glasses after immersion in Tris-HCl (not shown) are almost 
similar to the spectra of their corresponding parent glasses (Figure 4.9a). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.11 (a) The graphs depicting change in pH; (b) ICP plots of elemental concentration of 
Ca, Mg, P, and Si; (c) weight loss of glasses in Tris-HCl a function of FA content in glasses. 
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8. Biodegradation of glass-ceramics in simulated body fluid (SBF) and Tris-HCl 
The elemental release profile of glass-ceramics (sintered at 850 
o
C for 1 h) in SBF as 
measured by ICP-OES has been presented in Figure 4.12. The following observations can be 
made:  
i) The concentrations of Ca and Mg show similar increasing trends along the soaking time 
for all glass-ceramics corresponding to forward dissolution rate. The maximum Ca and 
Mg concentrations in SBF were obtained for glass-ceramic FA-20 with glass-ceramic 
FA-10 exhibiting the second highest leaching behaviour. In the cases of glass-ceramics 
FA-0, FA-30 and FA-40, a saturation plateau for Ca and Mg species are attained after the 
first 24 h. These results are in good co-relation with amorphous/crystalline ratio in glass-
ceramics. The compositions with highest amorphous/crystalline ratio exhibited highest 
leaching ability while increasing crystallinity in glass-ceramics decreased their surface 
reactivity. The increasing Ca concentration in SBF with increasing immersion time imply 
towards the initiation of the bio-mineralization process, where modifier cations in the 
glass exchange with hydronium ions in the external solution [14].  
ii) The trend of phosphorus concentration after soaking corresponds to an overall increase 
for all glass-ceramics. In case of compositions FA-10 and FA-20, phosphorus 
concentrations reached maximums after 7 days of their immersion in SBF and then 
decreased considerably. The phosphorus concentration in SBF after 7 days of immersion 
was highest for glass-ceramic FA-20 and second highest for glass-ceramic FA-10. The 
increase in phosphorus concentration until 7 days of immersion time may be attributed to 
either the release of additional soluble phosphate species or to a fast hydrolysis of small 
amounts of labile P-O-Si bridges from the residual glassy phase in the fluid, which might 
lead to local super-saturation and accelerate the HA precipitation from solution [14]. This 
rise in phosphorus concentration apparently coincides with initial stage of the reactivity 
mechanism features, the formation of Si–OH groups on the glass surface. Further, the 
decrease in phosphate concentration after 7 days of immersion in SBF is due to migration 
of phosphorus ions to glass surface to form calcium phosphate rich layers [14].  
iii) Among all the investigated glass-ceramics, the Si ion concentration in SBF was highest 
after 7 days for composition FA-20 and second highest for glass-ceramic FA-10. The 
lowest Si leaching ability was exhibited by GC FA-0 and FA-40. The loss of silica  
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Figure 4.12 ICP-OES plots of elemental concentration of (a) Ca, (b) Mg, (c) P, (d) Si, in SBF 
solution vs. immersion time for the investigated glass-ceramics 
 
 
species from glass-ceramic indirectly enhances the bioactive behaviour, through the 
surface Si-OH groups generated in the Si-O-Si hydrolysis process, which in turn decrease 
the interface energy between hydroxyapatite and glass-ceramic [31]. The soluble silica 
species are also thought to play a direct role as nucleation centres for precipitation of 
calcium phosphate; new applications of bioactive glass-ceramics as scaffolds for in vitro 
tissue engineering require the direct action of released silica and calcium in activating 
genes, which induce osteoblast proliferation [32]. 
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In general, a pH > 8 was achieved for all the glass-ceramics after immersion in SBF for 3 
days except glass-ceramic FA-0 (Figure 4.13). As has been reported in section 6.2, at pH > 8 
(weak base), carbonate formation is preferred instead of HA [17]. The SEM images of glass-
ceramic samples after immersion in SBF solution for different time periods are presented in 
Figure 4.14. As is evident from 4.14a, no apatite-layer formation occurred on glass-ceramic FA-
0 after 14 days of immersion in SBF. This may be attributed to its low residual glassy phase 
content i.e. ~2 wt% as calculated from XRD data. It is worth mentioning that glass-ceramic FA-0 
corresponds to stoichiometric diopside (CaMgSi2O6) composition which is a proven biomaterial 
for bone regeneration, tissue engineering [33] as well as drug delivery [34]. However, in the 
present case, this material proved out to be non-bioactive after sintering its precursor glass at 850 
ºC for 1 h. This difference in surface active behaviour of diopside based ceramics may be 
attributed to different synthesis routes and amorphous/crystalline ratio. For example, diopside 
based bioactive glass-ceramics as synthesized by Yoganand et al. [35] contained a high amount 
of residual glassy phase as was clear from their XRD data. Nevertheless, in vivo tests will be  
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Figure 4.13 The graphs of pH of SBF solution as a function of 
immersion time duration for the investigated glass-ceramics. 
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crucial in order to determine the actual bone bonding ability of glass-ceramic FA-0. Further, 
FA containing compositions FA-10 and FA-20 exhibited formation of apatite like layer on their 
surfaces after immersion in SBF after 14 days as has been presented in Figure 4.14b. The Ca/P 
ratio as calculated from EDS analysis on these samples varied between 1.6-1.7 indicating 
Figure 4.14 SEM images of glass-ceramics after immersion in SBF (a) FA-0 for 14 days, 
(b) FA-10 for 14 days, (c) FA-10 for 28 days, (d) FA-20 for 28 days, (d) FA-30 for 28 days, 
respectively.  
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towards the precipitation of calcium phosphate layer on their respective surfaces. The intensity 
of apatite formation on glass-ceramics FA-10 and FA-20 increased significantly with increase 
in immersion time from 14 to 28 days (Figure 4.14c and Figure 4.14d). The apatite-like layer 
was also observed on the surface of glass-ceramic compositions FA-25 and FA-30, 
respectively but only after 21 days of immersion in SBF (Figure. 4.14e) while low apatite 
forming tendency was observed for glass-ceramic FA-40 in accordance with ICP-OES results. 
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The variation in pH and weight loss of glass-ceramics with respect to FA content after 
soaking in Tris–HCl is presented in Figure 4.15a. The pH in case of glass-ceramic FA-0 is 
almost equivalent to the pH of the freshly prepared Tris-HCl solution indicating towards its 
negligible degradation and weight loss in solution owing to its low amorphous content. ICP-OES 
results, as presented in Figure 4.15b, are in good agreement with pH and weight loss results as 
glass-ceramic FA-0 exhibits lowest leaching of Ca and Mg ions in the solution among all the 
investigated glass-ceramic compositions. The introduction of FA enhanced the dissolution 
behaviour of the investigated glass-ceramics due to their higher residual glassy phase, thus 
leading to an increase in pH as well as weight loss. The highest weight loss among all the 
investigated compositions was observed for glass-ceramic FA-10 owing to highest leaching of 
Ca and Mg ions from this sample in Tris-HCl solution (Figure 4.15b) due to dissolution of 
charged ion pairs (CaF)+ or (MgF)
+. Further increase in FA content (≥ 30 wt%) led to decrease 
in leaching ability of glass-ceramics, thus resulting in decreases in pH and weight loss. Among 
all the investigated glass-ceramic compositions, 45S5 Bioglass
®
 exhibited highest weight loss of 
>3 wt%, thus proving its high dissolution rate. The XRD data of glass-ceramics after immersion 
in Tris-HCl did not reveal any significant changes in their crystalline phase assemblage in 
comparison to their parent glass-ceramics (Figure 4.15c).  
With respect to the elemental release profile of glass-ceramics in Tris-HCl, previous 
studies have shown that Si release levels in the range 0.1 to 100 ppm [36, 37] from bioactive 
glasses and other biomaterials show stimulatory effects on osteoblasts and the expression of 
TGF-β mRNA in human osteoblast-like cells. Additionally, Si administration has been known to 
prevent trabecular bone loss and a silicon-deficient diet results in impaired collagen synthesis 
and defective skeletal structure [38]. Furthermore, gradual release of soluble silica over time may 
not only increase cytocompatibility but may also enhance bone bonding due to the increased 
formation of SiOH (silanol) groups, which are known to play an active role in the precipitation 
of calcium phosphate. In the present study, the concentration of Si species in Tris-HCl varied 
between 65  78 ppm (1 ppm = 1 mg l1) which is in the range of attributing beneficial properties 
towards various biological processes.  
Further, Ca
2+
 ion release from glass-ceramics in Tris-HCl solution varied between 109  
348 ppm. Although, the significance of Ca in the process of bone mineralization is well 
established, the ability of extracellular Ca to regulate cell specific responses has been 
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demonstrated few years back [39]. Increased levels of extracellular Ca (13.1 to 90 ppm) have 
been shown to induce osteoblast proliferation and chemotaxis through binding to a G-protein 
coupled extracellular calcium sensing receptor and its gradual release over time may enhance 
therapeutic efficacy [37, 38].   
Furthermore, increasing FA/Di ratio in glass-ceramics affected the elemental release 
profile of phosphorus as its concentration decreased from 1.6 ppm (FA-10) to 0.1 ppm (FA-40) 
in Tris HCl. Phosphorus release from biomaterials in controlled amounts (< 30 ppm) has been 
shown to favour biomineralization and induce expression of osteogenic messenger RNA 
transcripts while an increase in concentration of phosphorus beyond 30 ppm results in decrease 
in cell viability [40]. Meleti et al. [40] showed that treatment of human osteoblast like cells with 
31 ppm – 217 ppm phosphorus exhibited a dose- and time dependent decrease in cell viability as  
 
a dose of 217 ppm of phosphorus caused an almost complete loss of osteoblast viability in 96 h. 
In the present study, the ionic concentration of phosphorus released from diopside – fluorapatite 
glass-ceramics lies within the dose limit in order to promote favourable biological activity.  
Figure 4.16 MTS cell viability showing the cell growth kinetics on the GC 
groups (FA-0, FA-10 and FA-20) and tissue culture plastic used as a positive 
control during culture for 3, 7 and 14 days. Mesenchymal stem cells (MSCs) 
from rat bone marrow were used for the assay. Statistically significance 
difference was noticed between groups; control vs. FA-0, FA-10 or FA-20 (
*
p < 
0.05) and FA-0 vs. FA-10 or FA-20 (
#
p < 0.05). ANOVA for n = 3. 
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The level of magnesium in the 
extracellular fluid ranges between 17 ppm 
and 25.5 ppm, where homeostasis is 
maintained by the kidneys and intestine 
[41, 42]. In the present study, the 
concentration of magnesium released 
from experimental glass-ceramics in Tris-
HCl varied between 20 ppm (FA-0) and 
149 ppm (FA-10) which is significantly 
higher than the dose required for 
favourable biological activity. However, 
it is noteworthy that although serum 
magnesium levels exceeding 25.5 ppm 
can lead to muscular paralysis, 
hypotension and respiratory distress [42], 
and cardiac arrest occurs for severely high 
serum levels of 145–170 ppm, the 
incidence of hyper-magnesium is rare due 
to the efficient excretion of the element in 
the urine [42, 43].  
 
9. Cell culture studies on glass-
ceramics  
Figure 4.16 shows the cell 
viability on the glass-ceramic groups and 
control during culture for up to 14 days, 
as assessed by an MTS method. 
Apparently, the growth kinetics of the 
FA-0 group was substantially reduced 
with respect to that of tissue culture 
Figure 4.17 SEM morphologies of MSCs 
grown on the glass-ceramic samples during 
culture for 7 days; (A) FA-0, (B) FA-10 and 
(C) FA-20.  
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plastic control as well as to that of other glass-ceramic groups with significantly lower cell 
viability particularly at 3 and 7 days owing to its almost negligible residual glassy phase. 
However, the cell growth on FA-10 continued to increase further to 14 days, reaching the levels 
of other glass-ceramic groups. FA-10 and FA-20 samples appeared to show similar growth 
pattern to the culture dish control during the culture period although the cell viability on the 
glass-ceramic groups was also significantly lower than that of the culture dish control. The  
 
representative cell growth images at day 7 on glass-ceramic samples are presented in Figure 
4.17. The cells were not readily noticed on the FA-0 sample (Figure 4.17a). Many pores were 
developed on the sample and some cellular processes were observed bridging the pores 
(arrowed). It is deduced that the large amount of pores produced in the FA-0 sample might 
restrict the proliferative potential of cells. On the other hand, when grown on FA-10 (Figure 
4.17b) and FA-20 (Figure 4.17c), the cells were readily observed covering the surface almost 
Figure 4.18 ALP activity of MSCs determined after culture for 7 and 14 days on the 
GCs (FA-0, FA-10 and FA-20) and tissue culture plastic control. Statistically 
significance difference was noticed between groups; control vs. FA-0, FA-10 or FA-
20 (
*
p < 0.05) and FA-0 vs. FA-10 or FA-20 (
#
p < 0.05). ANOVA for n = 3.  
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completely with active cytoskeletal processes, and the result suggests the developed FA-10 and 
FA-20 groups provide MSCs favourable conditions to adhere, spread and proliferate.  
The osteogenic differentiation of the MSCs cultured on the glass-ceramic samples was 
investigated in terms of ALP activity (Figure 4.18). Under the osteogenic medium used herein, 
rat bone marrow MSCs have been shown to switch to the lineage of osteoblastic cells [44]. When 
cultured on the control dish, MSCs showed an increased ALP level from days 7 to 14. On the 
FA-0, the cells showed significantly higher ALP level particularly at day 14. The ALP activity 
was even further enhanced on FA-10 or FA-20 samples with respect to the cells on the FA-0. 
Based on the ALP activity assay, the MSCs demonstrated to be better stimulated to an osteogenic 
lineage when supported on the substrates of glass-ceramics, particularly in the groups containing 
FA composition (FA-10 and FA-20). This enhanced differentiation was possibly due in part to 
the change in the surface chemistry associated with the apatite deposition on the glass-ceramics 
as noticed in the acellular SBF tests. Moreover, the ionic releases from the samples should also 
affect the MSCs differentiation into osteoblasts in a positive manner. Although the optimal 
concentrations of the ions to be released from the samples that are effective in the cellular 
functions cannot be decisive in this study, it is considered that the effects should be more 
pronounced in the FA-10 and FA-20 with respect to FA-0 based on the much higher ionic 
releases in the FA-containing groups. Although more in-depth biocompatibility assessments are 
required in the future, the favourable responses of MSCs including growth behaviour and up-
regulated ALP expression support the potential usefulness of the developed Di-FA glass-ceramic 
systems in bone regeneration field.  
 
10. Summary 
We have studied the structure, sintering behaviour and bioactivity of glasses and resultant 
glass-ceramics in the system (100-x)(CaO•MgO•2SiO2) – x(9CaO•3P2O5•CaF2), where x varies 
between 10 – 40 wt%. The following points summarize the results obtained in this study: 
1. With respect to the glass forming ability, monolithic glasses (by casting the melt on a 
metallic mould) could be obtained for compositions with x = 10 – 30 wt% while glass 
frits (by quenching the melt in cold water) could be obtained for x = 0 – 40 wt%.  
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2. The silicate glass network in all the glasses is dominated by Q2 and Q3 while the 
phosphate component is predominantly coordinated in orthophosphate environment. 
These structural features are expected from a glass with good bioactivity [45]. 
3. The glass transition temperature decreases with increasing fluorapatite content in glasses, 
due to a gradual decrease in silica content, increase in CaO content and addition of CaF
+
 
species to the glass structure.  
4. The stoichiometric diopside glass (FA-0) exhibits single stage sintering behaviour with 
its temperature for maximum shrinkage coinciding with onset of crystallization, thus, 
rendering sintered glass-ceramics with very high crystallinity. 
5. Diopside featured as the only crystalline phase in glass-ceramics with x = 0 – 10 wt%.  
Fluorapatite emerged as a secondary phase in glass-ceramics with x ≥ 20 wt% and its 
concentration increased progressively with further increase in fluorapatite content. . 
6. An extensive calcite precipitation was observed for all the glasses after immersion in SBF 
solution for 1 h which masked the formation of hydroxyapatite. The tendency towards 
formation of calcite decreased with increasing fluorapatite content in glasses.  
7. The pH of Tris-HCl solution increased slightly with increasing fluorapatite content in 
glasses due to increasing dissolution of Ca and Mg ions owing to partial disruption of 
silicate glass network and the dissolution of charged ion pairs (CaF)+ or (MgF)
+
. It is 
due to this reason that highest weight loss (~1 wt%) in Tris-HCl was calculated for glass 
FA-40.  
8. The stoichiometric diopside glass-ceramic did not exhibit any apatite forming ability 
owing to its negligible amorphous content. The glass-ceramics FA-10 and FA-20 
exhibited appreciable densification level with highest amount of amorphous content 
which in turn led to high rate of apatite-forming ability on their surfaces with good 
biodegradation properties. 
9. In vitro responses of MSCs to the glass-ceramics with different compositions showed 
favourable growth behaviours on FA-10 and FA-20 whilst substantially slowed-down 
growth kinetics on FA-0. 
10. MSCs were supported to differentiate into an osteogenic lineage when cultured on all the 
glass-ceramics with respect to culture dish control, particularly with more significant 
stimulation on the FA-10 and FA-20. 
88 
 
 
 
 
 
 
 
 
 
 
 
  
89 
 
 
 
 
 
 
Section 4.2 
Understanding the structure and sintering ability of glasses in the 
diopside – fluorapatite – wollastonite system  
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1. Glass forming ability 
A series of glasses with varying CaO/MgO ratio have been synthesized in the system 
CaO−MgO−SiO2−P2O5−CaF2 with parent composition corresponding to 80 wt% 
(CaO•MgO•2SiO2) – 20 wt% (9CaO•3P2O5•CaF2). The glasses were prepared in Pt-Rh crucibles 
at 1590 ºC by melt-quenching technique. Table 4.3 presents the composition of glasses 
investigated in this study. All the glasses exhibited good glass forming ability and resulted in 
amorphous glass frit upon quenching of glass melt in cold water.  
   
Table 4.3 Chemical composition of glasses 
 
 CaO MgO SiO2 P2O5 CaF2 CaO/MgO 
W-10 mol% 34.12 18.76 42.52 3.45 1.15 1.82 
 wt% 32.97 13.03 44.02 8.44 1.55  
W-20 mol% 36.70 16.20 42.46 3.48 1.16 2.26 
 wt% 35.20 11.17 43.64 8.45 1.55  
W-30 mol% 39.32 13.60 42.41 3.50 1.17 2.89 
 wt% 37.44 9.31 43.27 8.43 1.55  
W-40 mol% 41.98 10.96 42.35 3.53 1.18 3.83 
 wt% 39.67 7.45 42.89 8.44 1.55  
W-50 mol% 44.68 8.28 42.29 3.56 1.19 5.40 
 wt% 41.91 5.58 42.50 8.45 1.55  
W-60 mol% 47.42 5.56 42.24 3.58 1.19 8.52 
 wt% 44.15 3.72 42.14 8.44 1.54  
W-70 mol% 50.21 2.80 42.18 3.61 1.20 17.93 
 wt% 46.39 1.86 41.76 8.44 1.54  
W-80 mol% 53.03 0.00 42.12 3.64 1.21 - 
 wt% 48.62 - 41.38 8.45 1.54  
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2. Structure of glasses 
In the present study, the room temperature FTIR transmittance spectra of all the 
investigated glasses (Figure 4.19) exhibit three broad transmittance bands in the region of 300-
1500 cm
1
. This lack of sharp features is indicative 
of the general disorder in the silicate and phosphate 
network mainly due to a wide distribution of Q
n
 
units occurring in these glasses. The most intense 
bands in the 800-1300 cm
1
 region correspond to 
the stretching vibrations of the SiO4 tetrahedron 
with a different number of bridging oxygen atoms 
[20]. This region (i.e. 800-1300 cm
1
) is split in 
two transmittance bands centred at ~1040 cm
1
 and 
~920 cm
1
. The high frequency band can be 
assigned to the Si-O asymmetric stretching mode 
of BOs, whereas the ~920 cm
1
 may be attributed 
to the Si-O asymmetric stretching mode of the 
NBOs [21, 22]. The 510 cm
1
 band can be 
attributed to Si-O-Si bending modes [21], while the 
weak 740 cm
-1
 shoulder may be due to Si–O–Si 
symmetric stretching with simultaneous Si cation 
motions [23]. It is noteworthy that the high 
frequency band at 1040 cm
1
 may also be assigned 
to the asymmetric stretching of PO4 units which 
has been reported to appear in crystalline fluorapatite at 1038 cm
1
 [24]. No significant 
differences in the infrared spectra of the investigated glasses could be observed thus depicting 
that varying CaO/MgO ratio in glasses did not affect the structure of glasses substantially. 
 In agreement with FTIR studies, the 
29
Si MAS-NMR spectra for all the investigated 
glasses (Figure 4.20a) depict the dominance of Q
2
 (Si) structural units in the glasses [4]. Further, 
only slight shift in the peak positions of spectra could be observed and all the spectra are centred 
between 82.2 ppm and 82.9 ppm, thus depicting no significant changes in the silicon 
Figure 4.19 FTIR spectra of glasses 
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coordination in glass structure. Similar results 
have been reported by Galliano et al. [46] where 
it has been shown that the type and distribution 
of silicate units in an alkaline-earth 
phosphosilicate glass does not depend on the 
nature of the alkaline-earth cations present in the 
system. Recent stuides by Pedone et al. [47, 48] 
and Goel et al. [7] have indicated that varying 
CaO/MgO or MgO/ZnO content in glasses does 
not affect the overall network connectivity of the 
glass and the number of NBOs remain 
unchanged.  
The 
31
P MAS-NMR spectra of all the 
glasses show a predominance of an 
orthophosphate-type environment (Figure 
4.20b). The observed chemical shifts, ~2 ppm, 
are close to that of the calcium orthophosphate 
(3.1 ppm) implying towards preferential 
coordination of calcium instead of magnesium 
with orthophosphate groups (
31
P chemical shift: 
0.5 ppm for amorphous magnesium 
orthophosphate). These observations are 
consistent with literature as magnesium is known 
to exhibit least affinity towards associating with 
phosphate groups in comparison to calcium or 
sodium [7, 49]. [4]. These results are in good co-
relation with those reported by Lusvardi et al. 
[10] and Linati et al. [6] for 45S5 glass where 
fraction of orthophosphate units has been 
calculated to be ~82% while the rest might be 
comprised of meta- or pyrophosphates. 
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Therefore, it can be considered that majority of the phosphate component in glass is not part of 
the actual glass network backbone. Recent studies have shown that for bioactive glasses with 
P2O5 <10 mol%, the fractional population of the orthophosphate groups remains independent of 
their P2O5 concentration at a fixed NC value, but is slightly reduced as NC increases [50, 51]. 
While the bioactivity generally displays a non-monotonic dependence of P2O5 concentration, 
literature suggests that it is merely the net orthophosphate content that directly links to the 
bioactivity [50-52]. 
 
3. Thermal behaviour of glasses 
 The DTA plots of glass powders, shown in Figure 4.21, feature an endothermic dip 
corresponding to glass transition temperature (Tg) before the ons et of crystallization (Tc) and a 
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Figure 4.21 DTA thermographs 
of investigated glasses at heating 
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. 
Figure 4.22 Influence of MgO on different 
thermal parameters of glasses as obtained by 
DTA. 
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well-defined single exothermic crystallization curve. The presence of single crystallization 
exotherm anticipates that the glass-ceramic is formed either as a result of single phase 
crystallization or of an almost simultaneous precipitation of different crystalline phases. Figure 
4.22 present the variation in Tg, Tc and peak temperature of crystallization (Tp) with increasing 
MgO content in glasses. As is evident from Figure 4.22, Tg shifted towards lower temperature 
values with increasing MgO content in glasses. This may be attributed to magnesium entering 
the silicate glass network as tetrahedral MgO4 units [53]. According to Watts et al. [49], Si–O–
Mg bonds  have, on average, a significantly lower bond strength with respect to Si–O–Si bonds 
in the silicate chain, and therefore, resulting in the observed reduction in Tg.  This is also a key 
feature for lowering melt viscosities of Mg-containing silicate glasses [54]. No significant 
variations in the values of Tc (880 ± 6 °C) and Tp (809 ± 6 °C) were observed with varying 
CaO/MgO ratio in glasses (Figure 4.22). 
With respect to the sintering ability of glasses, Figure 4.22 presents the variation in 
thermal stability parameter DT (= Tc – Tg) for all the investigated glasses. The higher values of 
DT correspond to delay in nucleation and thus, provide wider processing window for a glass 
composition to attain maximum densification. In the present study, increasing calcium content in 
glasses decreases the value of DT, thus implying towards degradation in sintering behaviour of 
glasses. However, still the values of DT obtained for all the investigated glasses are high enough 
to help glass powders attain good densification during sintering. These observations are in good 
agreement with the results of Karamanov et al. [55] where it has been reported that wollastonite 
(CaO•SiO2) based glass-ceramics possess lower mechanical strength in comparison to  diopside  
(CaO•MgO•2SiO2) based glass-ceramics. 
In accordance with DTA results, well sintered glass-ceramics were obtained after 
sintering of glass powders at 850 ºC for 1 h. As is evident from Figure 4.23, the XRD results 
reveal the presence of diopside (CaMgSi2O6; ICDD card: 01-078-1390), fluorapatite 
[Ca5(PO4)3F; ICSD: 01-071-3848], and wollastonite (CaSiO3; ICSD: 20589) in the crystalline 
phase assemblage of all the glass-ceramics except composition W-80 which is MgO-free. As is 
evident from the intensity of XRD phase reflections, the starting glass composition (W-10) 
comprised mainly of residual amorphous glassy phase which decreased with increasing 
CaO/MgO ratio in glasses until composition W-50. Wollastonite dominated the crystalline phase 
assemblage of glass-ceramics W-50, W-60 and W-70. Further increase in CaO/MgO ratio in 
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glasses led to decrease in crystallinity in glass-ceramics. The residual glassy phase in glass-
ceramics is of crucial importance as it controls the apatite forming ability of glass-ceramics [56, 
57] and the glass-ceramic may turn bio-inert if residual glassy phase is in low amount (< 5 wt%). 
Thus, the design of glass-ceramic compositions needs to be such that equilibrium is achieved in 
the midst of biological and mechanical properties of the final material. In the present 
investigation, the amount of residual glassy phase is high enough to render good bioactivity to 
resultant glass-ceramic material.  
 
The microstructure of glass-ceramics as observed by SEM (Figure 4.24) is in good agreement 
with XRD results. The SEM images of glass-ceramics W-10 (Figure 4.24a) and W-20 (Figure 
4.24b) exhibit highly dense microstructure implying towards good sintering behaviour of glass-
ceramics. Although, the glass-ceramic compositions W-70 and W-80 possess almost similar or 
Figure 4.23 X-ray diffractograms of glass powder compacts sintered at 850 °C for 1 h 
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Figure 4.24 SEM images of glass-ceramics (a) W-10, (b) W-20, (c) W-70 and (d) W-80 after 
sintering at 850 
o
C for 1 h. 
higher amount of residual glassy phase than W-10, still the degradation in sintering ability of 
these glass compositions may be attributed to the variation in the amount of porosity in these 
glass-ceramics owing to their different nature and amount of crystalline content. According to 
Karamanov et al. [38], both diopside as well as wollastonite based glass-ceramics possess good 
sintering ability. However, due to crystallization volume fraction of diopside and wollastonite, 
intragranular crystallization induced porosity is formed in these glass-ceramics which affects the 
sintering ability of these glass-ceramics, thus resulting in poor mechanical strength of 
wollastonite based compositions. This explanation is concurrent with the microstructure of glass-
ceramics W-70 (Fig. 4.24c) and W-80 (Fig. 4.24d), respectively. 
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4. Summary 
The influence of varying CaO/MgO ratio on the structure, sintering and crystallization 
behaviour of diopside-fluorapatite based glasses and glass-ceramics has been investigated. The 
variation in CaO/MgO ratio on glasses did not exhibit any significant effect on the structure of 
glasses with Si predominantly present in Q
2
 units while phosphate is coordinated in 
orthophosphate environment. With respect to thermal behaviour of glasses, heat treatment of 
glass powders at 850 ºC for 1 h resulted in well sintered glass-ceramics with diopside, 
fluorapatite and wollastonite as the crystalline phases. Increasing CaO/MgO ratio in glasses 
degraded their sintering behaviour and resulted in different amorphous/crystalline ratio in 
resultant glass-ceramics. Considering the sintering ability of glasses (DT) along with 
amorphous/crystalline phase assemblage in resultant glass-ceramics (from the intensity of XRD 
phase reflections), composition W-30 appears to be a good candidate for further experimentation 
as potential material for scaffold fabrication.  
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Section 4.3 
Understanding the influence of Na2O on the structure, bioactivity 
and sintering ability of glasses in diopside – fluorapatite – 
wollastonite system  
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1. Glass forming ability 
A series of glasses with compositions expressed as (16.20–
x)MgOxNa2O37.14CaO3.62P2O542.46SiO20.58CaF2 (in mol%), where x varies between 0 
– 10 has been prepared by melt-quenching technique. The glasses have been labelled in 
accordance with their respective Na2O content, i.e. Na0, Na2, Na4, Na6, Na8 and Na10. 
The alkali-free parent glass composition (Na-0) has been designed in the glass forming region of 
diopside (CaO•MgO•2SiO2) – fluorapatite (9CaO•3P2O5•CaF2) – wollastonite (CaO•SiO2) 
system. The glasses were prepared in Pt-Rh crucibles at 1550 ºC by melt-quenching technique. 
We could obtain homogeneous, transparent and amorphous monolithic annealed glasses 
(annealing at 500 ºC) as well as frit (by quenching in cold water). 
 
2. Structure of glasses 
Table 4.4 Density and molar volume of glasses 
Glass Density   
(g cm
3
) 
Molar volume 
(cm
3
 mol
1
) 
Excess volume 
(cm
3
 mol
1
) 
Na-0 2.92±0.004 20.03±0.027 0.062±0.027 
Na-2 2.90±0.006 20.71±0.040 1.635±0.040 
Na-4 2.88±0.007 20.56±0.050  0.053±0.013 
Na-6 2.87±0.004 20.78±0.028  0.147±0.028 
Na-8 2.86±0.004 21.05±0.026  0.205±0.026 
Na-10 2.85±0.003 21.30±0.025  0.27±0.025 
 
The experimental results showed that increasing Na2O/MgO ratio in glasses resulted in 
lowering their density (ρ) (Table 4.4). Since density of a glass is an additive property and density 
of Na2O (2.27 g cm
3
) is lower than that of MgO (3.58 g cm
3
), therefore, decrease in density 
with increasing Na2O content is logical. As is usually observed in most oxide glass systems, 
decrease in density results in increase in their molar volume as is evident from Table 4.4. Since 
the addition of Na2O at the expense of MgO results in the formation of less directed bonds, the 
structural skeleton collapses into a closer packing, thus, leading to decrease in excess molar 
volume (Table 4.4). In coherence with the excess volume data, a decreasing trend was observed 
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for Tg due to the gradual decrease of degree of cross-linking in the silicate network (Figure 4.25). 
An increase in the polarizability arises from the negatively charged non-bridging atoms. 
Consequently, both anharmonicity of thermal vibrations [58] and CTE (200–500 ºC) increase 
(Figure 4.25). 
Figure 4.26a presents the 
29
Si MASNMR spectra for all the investigated glasses depicting 
the dominance of Q
2
(Si) structural units in the glasses. The maximum of the 
29
Si NMR resonance 
slightly shifted from 81.8 ppm, for glass Na0, to 80.8 ppm for glass Na10, which could be 
interpreted as a slight depolymerisation of the silicate glass network with the increase of the 
sodium content at the expense of MgO. The change in the chemical shift to lower field may be 
attributed to the difference in ionic field strength of sodium and magnesium modifiers. The 
higher ionic field strength of MgO makes the chemical shift to move towards higher field while 
the incorporation of Na2O (with lower ionic field strength) at the expense of MgO shifts the 
resonance to a lower field [49].  
 The 
31
P MAS NMR spectra of all glasses (Figure 4.26b) exhibit the predominance of an 
orthophosphate-type environment (Q
0
). The maximum of 
31
P NMR spectra varied between 2 
ppm – 4 ppm for the studied glasses implying towards preferential association of calcium with 
amorphous orthophosphate species (chemical shift for Ca3(PO4)2 is at 3 ppm). The positive shift 
in 
31
P NMR spectra with increasing Na2O content indicates increasing association of sodium 
with orthophosphate groups (the chemical shift for Na3(PO4) species is at 14 ppm). However, 
calcium is still preferentially associated with phosphate groups due to its significantly higher 
concentration in comparison to sodium. As has been discussed in section 4.2, magnesium 
exhibits poor affinity towards association with phosphate groups. Therefore, in concurrence with 
31
P NMR results, we do not expect significant amount of amorphous magnesium orthophosphate 
species in these glasses. 
3. In vitro biodegradation of glasses 
The XRD patterns observed for all as-quenched glasses (i.e. before soaking in SBF 
solution; not shown) exhibit a broad amorphous halo depicting the absence of crystallinity in 
glasses. The room temperature FTIR transmittance spectra of all the investigated glasses are 
shown in Figure 4.27. In general, FTIR spectra of all the investigated glasses exhibit three broad 
transmittance bands in the region of 3001300 cm1. This lack of sharp features is indicative of 
the general disorder in the silicate and phosphate network mainly due to a wide distribution of Q
n
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units occurring in these glasses. The most 
intense bands in the 8001300 cm1 
region correspond to the stretching 
vibrations of the SiO4 tetrahedron with a 
different number of bridging oxygen 
atoms [20]. Further, in all the glasses, this 
region (i.e. 8001300 cm1) is split in two 
transmittance bands centred at ~1045 
cm
1
 and ~920 cm
1
. The high frequency 
band can be assigned to the SiO 
asymmetric stretching mode of BOs, 
whereas the ~920 cm
1
 may be attributed 
to the SiO asymmetric stretching mode 
of the non-bridging oxygens (NBOs) [20, 
21]. Furthermore, the 500 cm
1
 band can 
be attributed to SiOSi bending modes 
[25], while the weak 740 cm
1
 shoulder may be due to Si–O–Si symmetric stretching with 
simultaneous Si cation motions [22]. It is noteworthy that the high frequency band at 1045 cm
1
 
may also be assigned to the asymmetric stretching of PO4 units which has been reported to 
appear in crystalline fluorapatite at 1038 cm
1
 [59]. 
Although the XRD data of glass powders after immersion in SBF solution for time period 
varying between 1 – 3 days exhibits a broad amorphous halo (Figure 4.28a), the FTIR spectra of 
these glass samples depict several changes in the glass structure that occurred due to the reaction 
between glass and SBF (Figure 4.29). The immersion of glass powders in SBF for 1 h resulted in 
the splitting of strong low frequency band in the region 350 – 650 cm−1 into small bands at ~465 
cm
−1
, ~570 cm
−1
 as is evident from Fig. 4.27. The band centered at 465 cm
−1
 can be ascribed to a 
deformation mode of silica layer that develops on the dissolving glass particles [28] while small 
broad bands at 570 cm
−1
 corresponds to PO bending vibrations in a PO4
3−
 tetrahedron implying 
towards the presence of non-apatitic or amorphous calcium phosphate, which is usually taken as 
an indication of presence of precursors to HA. The main IR band now occurs at 1060 cm
1
 and a 
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Figure 4.27 FTIR spectra of the studied glasses 
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nearby shoulder, centred 
at ~1225 cm
1
 and 
attributed to SiOSi 
vibration [25] can be 
observed in all the 
glasses, due to the 
interfacial formation of 
high-area silica gel layer, 
as postulated in Hench’s 
inorganic reaction set. 
Further, twin peaks at ~ 
1420 cm
1
 and ~ 1500 
cm
1
, corresponding to 
the formation of complex 
carbonate species 
connected with the 
presence of Ca
2+
 ions in 
the surface [17], appear 
in all the glasses. The 
FTIR and XRD data are 
in good agreement with 
each other as neither of 
the two indicated towards 
the precipitation of 
carbonated HA on the 
glass surface during 
initial 72 h of immersion 
in SBF solution as is 
evident from Figure 
4.28a and Figure 4.29. The XRD spectra of glass powders after immersion in SBF solution for 7 
days exhibit broad phase reflections corresponding to the formation of HA as is evident from 
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Figure 4.28 X-ray diffractograms of (a) glass Na-6 after 
immersion in SBF solution for time period varying between 1 h 
– 7 days; and (b) all glasses after immersion in SBF solution for 
7 days. 
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Figure 4.29 FTIR spectra of glasses after immersion in SBF solution for (a) 1 h; (b) 3 h; (c) 12 h. 
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Figure 4.29 FTIR spectra of glasses after immersion in SBF solution for (a) 24 h; (b) 3 days; (c) 7 days. 
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Figure 4.28b. In 
agreement with the 
XRD data, the 
FTIR spectra of 
these glasses 
resulted in splitting 
of broad parent 
absorption bands 
into a number of 
sharp bands 
(Figure 4.29f). For 
example the bands 
at 563 cm
1
 and 
605 cm
1
 along 
with bands at ~800 
cm
−1
, 850 cm
−1
, 
1420 cm
1
 and 1495 
cm
−1 
correspond to 
carbonated HA.  
The most 
interesting feature as 
observed from FTIR 
data of glasses 
immersed in SBF 
solution for 1 – 12 h 
is the diminishing 
intensity of band at 
~570 cm
1
 
characteristic for 
presence of 
amorphous calcium phosphate layer with increasing alkali-content (Fig. 4.29a-c). This 
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observation may be attributed to the decreasing chemical durability of glasses with increasing 
alkali content which does not allow the amorphous calcium phosphate layer to adhere to the 
glass surface during initial hours of immersion in SBF solution. According to the results obtained 
from AIMD simulations on 
sodium migration pathways in 
bioactive silicate glasses 
conducted by Tilocca [29], the 
transport of sodium to the glass 
surface and its release are key 
steps leading to the biological 
activity of these glasses. The 
calcium release, needed for the 
later stages of interfacial bonding 
takes place only after most Na 
ions have been released. 
Therefore, the Na:Ca ratio and 
their mutual interaction play a 
central role in the properties of 
these glasses related to the ionic 
solubility. In case of glasses under current investigation (SiO2<50 mol%), the low site selectivity 
of Na and the high flexibility of the glass network (compared to the more rigid higher silica 
glasses) might allow Na to move through Ca  sites, temporarily vacated by hosted cation. This 
explains some delay in formation of the amorphous calcium phosphate layer on surfaces of 
glasses.  
The variation in pH of Tris–HCl with respect to immersion time and Na2O content in 
glasses is presented in Figure 4.30 while Figure 4.31 shows a comparison between weight loss 
and the elemental concentration of sodium released from glasses after immersion of glass 
powders in Tris-HCl for 5 days. An increase in pH from 8.04±0.01 to 8.38±0.05 was observed 
with increasing Na2O content in glasses due to the preferential leaching of alkali ions from 
glasses in comparison to low mobility alkaline-earth cations as have been discussed above. All 
the glasses were amorphous after immersion in Tris-HCl (not shown), confirming that no 
Figure 4.32 Influence of Na2O on cell viability of MSC 
cultured on glass specimens as a function of time. 
Tissue culture plastic has been used as control. MSCs 
derived from rat bone marrow were used for the assay. 
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crystalline phase has been formed as a result of 
any chemical interaction between the dissolution 
products. 
The preferential leaching of sodium ions 
from these glasses resulted in sudden release of 
alkali caused a cytotoxicity effect as concluded 
from the preliminary in vitro osteoblast 
proliferation studies performed on these glasses 
(Figure 4.32). Although cells initially (at day 1) 
adhered well on all the glass samples, with 
adhesion level comparable to that of the tissue 
culture plastic control, the cell growth for 
prolonged period (7 and 14 days) was 
significantly different. The sodium-free parent 
glass (Na0) exhibited highest cell proliferation 
over the period of 14 days with the growth level 
similar to that of control, while incorporation of 
sodium in glasses decreased the cell viability 
considerably reducing it to minimal value even 
for the glass with lowest Na2O concentration 
(Na2). Similar results have been reported by 
Wallace et al. [60] and may be explained on the 
basis of faster release of alkali ions over calcium 
(required for cell viability and interfacial 
bonding) as explained by Tilocca [29].  
4. Sintering behaviour of glasses  
Figure 4.33a presents DTA thermograph 
of glass Na-6 while Figure 4.33b presents the 
DTA thermographs of all the glasses investigated 
in the present study. Table 4.5 presents the values of thermal parameters obtained for all the 
glasses from DTA. The glass transition temperature (Tg) decreases with increasing Na2O content  
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Figure 4.33 DTA thermograph of (a) 
glass Na-6, (b) all the glass investigated 
in this study. Heating rate = 20 K min
-1
.  
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Table 4.5 Thermal parameters obtained from DTA at 20 K min
-1
 
Glasses g Tc Tp1 Tp2 DT  
Na-0 760 915 946 - 155 
Na-2 725 894 918 - 169 
Na-4 700 875 901 - 175 
Na-6 684 862 890 - 178 
Na-8 669 845 890 - 176 
Na-10 645 785 822 882 140 
 
Table 4.6 Thermal parameters obtained from DTA and HSM at 5 K min
-1
 
Glasses TFS TMS1 TMS2 Tc Sc  
Na-0 758 809 893 878 69 
Na-2 725 789 - 857 68 
Na-4 700 770        - 845 75 
Na-6 680 745 - 830 85 
Na-8 673 740     830 802 62 
Na-10 656 720 - 745 25 
 
in glasses. This thermal event is then followed by onset of crystallization (Tc) and peak 
temperature of crystallization (Tp). The exothermic crystallization curve tends to shift gradually 
towards lower temperatures with increasing alkali content, further, splitting in two distinct 
features for glass Na-10 as shown in Figure 4.33b. The appearance of single exothermic curve 
implies that either the glass-ceramic formed as a result of crystallization is mono-mineral or 
different crystalline phases precipitate from the parent glass almost simultaneously. The addition 
of Na2O decreases the viscosity of glasses leading to lowering the activation energy of 
crystallization due to which we can observe the decrease in crystallization temperatures. The 
splitting of exothermic curve in two distinct features for glass Na-10 implies towards the 
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formation of two or more crystalline 
phases in a narrow temperature 
interval range. Since the glass 
compositions have been designed in 
the primary crystallization field of 
diopside and fluorapatite, both of 
these phases are expected to appear 
in these glass-ceramics. However, 
owing to the lower activation energy 
of crystallization of fluorapatite 
(~350 kJ mol
-1
 [61]) in comparison 
to diopside (~570 kJ mol
-1
 [62]), the 
crystallization of former should be 
preferred in glass Na-10.  
The characteristic thermal 
parameters, Tg, Tc, Tp and thermal 
stability, defined as ΔT(= Tc − Tg) 
obtained from DTA thermographs 
are summarized in Table 4.5. The 
values of DT varied between 140 – 
178 for all the glasses and increased 
with initial substitution of Na2O (0 - 
4 mol%) for MgO as have been 
shown in Table 4.5. Further increase 
in Na2O concentration in glasses 
between 4 – 8 mol% did not exhibit 
significant influence on their 
thermal stability as the average DT 
value for these glasses was 
calculated to be 176 ºC. However, 
increasing the Na2O content to 10 
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Figure 4.34 DTA and HSM curves for glasses (a) 
Na-0, (b) Na-2 and (c) Na-4 at 5 K min
-1
. 
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mol% led to considerable decrease 
in the thermal stability of glass Na-
10 with its DT = 140 ºC. The 
difference between Tc and Tg is an 
empirical and qualitative parameter 
that assists in deciding the 
processing window for glasses 
aimed for their application as 
coatings or scaffold fabrication as 
higher value of DT indicates 
delayed nucleation and good 
sintering ability [63]. A detailed 
analysis of sintering and 
crystallization behaviour of glasses 
has been made through DTA and 
HSM as discussed below.  
Figure 4.34 presents DTA 
and HSM data at heating rate ( =5 
K min
-1
) pertaining to sintering and 
devitrification behaviour of glasses 
that allow observation of the 
following trends:  
(i) The temperature of first 
shrinkage (TFS; log = 9.1 ± 
0.1, is viscosity; dPa s) 
decreased linearly with 
increasing sodium content in 
glasses with its value 
varying between  758 ºC for 
glass Na-0 and  656 ºC for 
glass Na-10 (Table 4.6).  
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(ii) The temperature of maximum shrinkage (TMS; log = 7.8 ± 0.1), and sintering ability, 
Sc (Tc – TMS) parameters have been presented in Table 4.6. The decrease in the value 
of Sc implies towards poor densification [13]. In concurrence with the values obtained 
for DT, the values of Sc indicate that initial incorporation of Na2O (0  6 mol%) in 
glasses facilitated their sintering. However, further increase in Na2O content led to the 
decrease in Sc values depicting the poor densification. The poor sintering ability with 
increasing sodium content in glasses has also been observed in other alkali-containing 
silicate glass systems [64] and is a major drawback for 45S5 Bioglass [65, 66]. The 
primary reason attributed to the poor densification of alkali-rich bioactive glasses is 
their high crystallization tendency [63, 64].  
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Figure 4.35 X-ray diffractograms of glass powder compacts sintered at 850 ˚C 
for 1 h. 10 wt% Al2O3 has been added to samples as an internal standard. 
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(iii) Two-stage shrinkage behaviour was observed for all the sodium containing glasses 
except Na-10 and can be attributed to the presence of glass-in-glass phase separation due 
to the presence of silicate and phosphate rich phases. However, increasing alkali 
concentration in glasses promoted crystallization of fluorapatite in glasses thus, hindering 
the second stage of sintering.  
 
Table 4.7 Linear shrinkage and flexural strength of sintered glass-ceramics 
 Shrinkage (%) 
Flexural Strength 
(MPa) Weibull m 
Weibull 0 
(MPa) 
Na-0 12.32±0.22 137±12 11.19 142 
Na-2 12.16±0.15 141±5 26.34 144 
Na-4 11.73±0.12 188±18 10.19 196 
Na-6 11.59±0.24 120±18 6.16 128 
Na-8 0 16±1 10.63 16 
Na-10 0 7±1 5.73 8 
 
The X-ray diffractograms of the glass powder compacts sintered at 850 
o
C for 1 h (Figure 
4.35) shows diopside (CaMgSi2O6; PDF card: 078-1390) as the main crystalline phase in all the 
glass-ceramics followed by fluorapatite [Ca5(PO4)3F; PDF card: 71-880] as the secondary phase.  
The 11%  12% linear shrinkage of sintered glass-ceramics (Table 4.7) with Na2O content 
varying between 0 – 6 mol% depicts good sintering ability, while further increase in Na2O 
content resulted in poor densification behaviour with almost negligible shrinkage. The 
mechanical strength results are in concurrence with the linear shrinkage data as the strength of 
glass-ceramics increases from 137±12 MPa (Na-0) to 188±18 MPa (Na-4) with increasing Na2O 
content from 0 to 4 mol%. However, further increase in alkali content in glasses decreased their 
mechanical strength with glass-ceramics Na-8 and Na-10 exhibiting values of 16 MPa and 7 
MPa, respectively. 
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5. Summary 
We have studied the influence of sodium on the structure, sintering behaviour and 
bioactivity of phospho-silicate glasses. The incorporation of Na2O at the expense of MgO 
induced slight depolymerisation in the silicate glass network as revealed by MAS NMR. 
Phosphorus was coordinated predominantly in orthophosphate environment and exhibited a 
positive chemical shift in 
31
P NMR spectra indicating the increasing coordination of sodium with 
phosphate component. FTIR results depict that increasing the alkali content in glasses led to the 
delayed formation of amorphous calcium phosphate layer on their surface when immersed in 
SBF solution. This delay was mainly due to the higher mobility of sodium in comparison to 
calcium from glass to the body fluid. The preliminary in vitro osteoblast proliferation studies 
performed on these glasses suggested that the increasing alkali-concentration in glasses led to 
cytotoxicity in the cell culture medium. 
With respect to sintering ability of glasses, incorporating Na2O in glasses to a 
concentration of 4 – 6 mol% facilitates their sintering and enhances their mechanical strength. 
Further increase in alkali content in these glasses significantly deteriorates their thermal stability 
and sintering behaviour, thus rendering porous and crystallized glass-ceramics with poor 
mechanical properties that are unfit for scaffold fabrication.   
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Section 4.4 
Understanding the influence of CaO/SiO2 and CaF2/P2O5 ratios on 
the structure, and sintering ability of bioactive glasses in diopside – 
fluorapatite – wollastonite system 
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1. Glass forming ability 
The present study describes the influence of varying SiO2/CaO and CaF2/P2O5 molar ratio 
on the thermal behaviour of glass compositions in the CaO-MgO-SiO2-P2O5-Na2O-CaF2 system 
designed in the primary crystallization field of diopside, fluorapatite and wollastonite. Table 4.8 
presents the compositions of glasses investigated in the present study. The melting temperature 
of 1450 ºC for 1 h was adequate to obtain highly homogeneous transparent and amorphous 
glasses for glasses 1d, 1d-a and 1d-b, respectively. However, the melting temperature was varied 
between 1450-1550 
o
C for glasses 1e, 1e-a, 1e-b and 1e-c with an increment of 25 
o
C for every 
glass composition due to possible increase in the refractoriness with increase in P2O5 content in 
the glasses [67].  
 
Table 4.8 Composition of glasses (mol%) 
Glass SiO2 CaO MgO P2O5 Na2O CaF2 CaO/SiO2 P2O5/CaF2 
1d 45.45 30.30 12.99 2.60 4.33 4.33 0.67 0.60 
1da 41.13 34.63 12.99 2.60 4.33 4.33 0.84 0.60 
1db 36.8 38.96 12.99 2.60 4.33 4.33 1.06 0.60 
1e 43.10 32.33 12.93 3.02 4.31 4.31 0.75 0.70 
1e-a 43.10 32.33 12.93 3.88 4.31 3.45 0.75 1.12 
1e-b 43.10 32.33 12.93 4.74 4.31 2.59 0.75 1.83 
1e-c 43.10 32.33 12.93 5.60 4.31 1.72 0.75 3.26 
 
2. Structure of glasses 
The density of glasses, as presented in Table 4.9, increased with increase in CaO/SiO2 
ratio (1d < 1d-a < 1d-b) due to the higher density of CaO ( = 3.34 g cm3) in comparison to 
SiO2 ( = 2.65 g cm
3
). On the other hand, it decreased with increase in P2O5/CaF2 ratio in the 
glasses (1e > 1e-a > 1e-b > 1e-c) (Table 4.9) due to the lower density of P2O5 (= 2.30 g cm
3
) 
in comparison with CaF2 ( = 3.18 g cm
3
). The molar volume (Vm) values decreased with partial 
substitution of SiO2 by CaO in the glasses (Table 4.9). The incorporation of network modifiers 
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Table 4.9 The properties of glasses as obtained from density, dilatometry, DTA and HSM. 
 CaO/SiO2  P2O5/CaF2 
 1d 1d-a 1d-b 1e 1e-a 1e-b 1e-c 
 (g cm-3) 2.84 ± 0.009 2.90 ± 0.003  2.93 ± 0.006 2.87 ± 0.007 2.86 ± 0.001 2.84 ± 0.002 2.82 ± 0.001 
Vm (cm
3
 mol
-1
) 20.85 ± 0.07 20.40 ± 0.02 20.13 ± 0.04 20.75 ± 0.05 21.03 ± 0.01 21.35 ± 0.02 21.68 ± 0.01 
Tdg  ± 2 (
o
C) 495 490 450 463 505 515 525 
Ts  ± 2 (
o
C) 673 673 657 674 673 680 689 
CTE x 10
6
 (K
-1
) 10.61 11.04 11.71 10.84 10.66 10.45 9.74 
TFS  ± 5 (
o
C) 640 642 630 664 673 683 688 
TMS  ± 5 (
o
C) 705 706 700 728 746 753 767 
Tc  ± 2 (
o
C) 804 800 778 805 820 837 852 
Tp1  ± 2 (
o
C) 831 826 794 835 844 815 799 
Tp2  ± 2 (
o
C) - - 817 - - 853 879 
A/A0 0.69 0.65 0.65 0.79 0.66 0.64 0.78 
Sc  99 94 78 77 74 84 85 
Ec1 (kJ mol
-1
) - - - 406 (0.991) 450 (0.996) 299 (0.998) 309 (0.999) 
Ec2 (kJ mol
-1
) - - - - - 303 (0.994) 285 (0.999) 
: density of glasses; Vm: molar volume; Tdg: dilatometric glass transition temperature; Ts: glass softening temperature; CTE: coefficient of 
thermal expansion; TFS: temperature of first shrinkage; TMS: temperature of maximum shrinkage; Tc: onset of crystallization; Tp: peak 
temperature of crystallization; A/A0: area at maximum shrinkage/initial area; Sc = Tc-TMS; Ec: Activation energy of crystallization (the 
values in parenthesis of Ec correspond to squared regression (r
2
); 5 data points per linear plot were used).  
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alters fundamentally the glass properties due to 
the formation of less directed bonds, leading to 
the collapse of structural skeleton into a closer 
packing [58]. Hence, owing to the reduced 
degree of cross-linking, molar volume 
decreases, Tg is lowered and CTE increases 
(Table 4.9). 
For glasses with varying P2O5/CaF2 ratio, 
the values of Vm, Tg and Ts were observed to 
increase while CTE decreased with increasing 
P2O5 content (Table 4.9). This behaviour may be 
attributed to the increase in the directional 
bonding in the glass structure or re-
polymerization in silicate glass network due to 
P2O5 addition as will be explained in next 
section.    
 The room temperature FTIR 
transmittance spectra of all the investigated 
glasses are shown in Figure 4.36a (varying 
CaO/SiO2 ratio) and Figure 4.36b (varying 
P2O5/CaF2 ratio) while the MAS-NMR spectra 
of selected glasses for 
29
Si and 
31
P nuclei are 
presented in Fig. 4.37. The FTIR spectra of 
45S5 Bioglass
®
 has been taken as a reference in 
order to make its structural comparison with the 
glasses under investigation (Figure 4.36a). As 
evident from Figure 4.36, it is noteworthy that 
despite of significant differences in the chemical 
composition of the investigated glasses in 
comparison to the composition of 45S5 
Bioglass
®
 the structure of all the glasses is 
45S5
1d
1d-a
1d-b
1040
1030
1005
738
755
738
705
930
926
860
495
503
516
300 500 700 900 1100 1300
Wavenumber (cm
-1
)
T
ra
n
sm
it
ta
n
ce
 (
a.
u
.)
(a)
1e
1e-a
1e-b
1e-c
1040
930
763
760
490
300 500 700 900 1100 1300
Wavenumber (cm
-1
)
T
ra
n
sm
it
ta
n
ce
 (
a.
u
.)
(b)
Figure 4.36 FTIR spectra of glasses (a) 
with varying CaO/SiO2 ratio and (b) 
with varying P2O5/CaF2 ratio. 
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similar to that of 45S5 glass. 
In general, infra-red spectra of 
all the investigated glasses 
exhibit three broad 
transmittance bands in the 
region of 300-1300 cm
1
. This 
lack of sharp features is 
indicative of the general 
disorder in the silicate and 
phosphate network mainly due 
to a wide distribution of Q
n
 
(polymerization in the glass 
structure, where n denotes the 
number of bridging oxygens) 
units occurring in these 
glasses. The most intense 
bands in the 8001300 cm1 
region correspond to the 
stretching vibrations of the 
SiO4 tetrahedron with a 
different number of bridging 
oxygen atoms [20]. For 
investigated glass 
compositions 1d, 1d-a (Figure 
4.36a) and all the glasses with 
varying P2O5/CaF2 ratio (Fig. 
4.37b), this band is around 
~1040 cm
1 
indicating the distribution of silicate Q
n
 units centered on Q
3
 [20, 68, 69]. It should 
be noted that the band near ~1030 cm
1
 (glass 1d-a) may also be attributed to PO3 end groups 
due to the presence of P2O5 glass network former in the investigated glasses [70]. Similarly 
1d
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1d-b
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29
Si Chemical shift (ppm)(a)
1d
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1d-b
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-30-150153045
31
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Figure 4.37 (a) 
29
Si and (b) 
31
P MAS-NMR spectra of 
glasses with varying CaO/SiO2 ratio.  
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transmittance bands near 930 cm
1
 may be attributed to the polymerization in silicate network 
structure with two bridging 
oxygens (Q
2
 units) [20, 68] 
along with some Q
1
 units.  
The FTIR results are in 
good agreement with NMR 
results as presented in Figure 
4.37. The peaks of 
29
Si spectra 
for all the investigated glasses 
(Figure 4.37a and 4.37) depict 
the dominance of Q
2
 (Si) 
structural units in the glasses 
[4]. However, increasing 
CaO/SiO2 ratio in glasses led 
to de-polymerization in 
silicate glass network as is 
evident from shift in the peak 
maxima for glass 1d-a and 1d-
b in Figure 4.37a while 
31
P 
NMR spectra for these glasses 
revealed the shift in peak 
position from 2.7 ppm to 2.9 
ppm (Figure 4.37b) with 
increasing CaO/SiO2 ratio thus 
implying towards the 
formation of calcium 
orthophosphate groups in the 
glasses [4]. On the contrary, 
increasing P2O5/CaF2 ratio in 
glasses led to the re-
polymerization in the silicate glass structure, thus shifting the peak maxima of 
29
Si NMR spectra 
1e
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Figure 4.37 (c) 
29
Si and (d) 
31
P MAS-NMR spectra of 
glasses with varying P2O5/CaF2 ratio.  
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(Figure 4.37c) from -82 ppm to -84 ppm which implies towards increasing number of Q
3
 (Si) 
units. These results are in good agreement with the experimental evidence of Lockyer et al. [2] 
that was interpreted on the basis of higher affinity of Na and Ca cations for phosphate groups, 
which are able to strip the modifier cations out of the silicate network, thus inducing re-
polymerization. It is noteworthy that while molecular dynamic (MD) simulations do confirm the 
above discussed results, they also highlight an addition factor that leads to re-polymerization in 
silicate glass network due to addition of P2O5: phosphorus can replace Na
+
 or Ca
2+
 in balancing 
Si–NBO bonds. Therefore, the silicate network re-polymerization can occur through either Si–
O–Si or Si–O–P new links. However, in the present case, we could not observe any change in 
peak maxima for spectra of 
31
P nucleus (2.9 ppm) with varying P2O5/CaF2 ratio (Figure 4.38d), 
thus neglecting the possibility of formation of Si–O–P new links. According to Tilocca [45], the 
highest bioactivity from a phospho-silicate glass can be expected if Q
n
 (Si) units are dominated 
by chains of Q
2
 metasilicates, which are occasionally cross-linked through Q
3
 units, whereas Q
1
 
units terminates the chains. The structure of the glasses under present investigation, specially 
glass 1d, glass 1d-a and all the glasses with varying P2O5/CaF2 ratio exhibit these features. 
Therefore, high bioactivity can be expected from these glasses. Further, the influence of an 
increase in CaO/SiO2 ratio is evident in the infrared spectra of glass 1d-b where the transmittance 
band in the region 800-1300 cm
-1
 shifts towards lower wave number, thus, depicting de-
polymerization in the silicate glass network (Figure 4.36a). These results further support our 
molar volume and dilatometry results. A shoulder observed at 860 cm
-1
 in glass 1d-b can be 
attributed to vibrations of Q
0
 units of silicate network structure. The bands around ~500 cm
-1
 and 
~740 cm
-1
 may be attributed to vibrations of various Q
n
 silicate units containing NBOs, 
suggesting of a high modification degree of the silicate network. Nevertheless, a study of the 
quantitative distribution of Q
n
 species for silicon, phosphorus and fluorine through nuclear 
magnetic resonance (NMR) spectroscopy will be needed to get a better insight into the structure 
of these glasses.                                                                       
 
3. Sintering and crystallization behaviour of glass powders 
Figure 4.38 presents variation in the relative area and heat flow with respect to 
temperature as obtained from HSM and DTA, respectively, for some of the investigated glass 
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compositions at a heating rate of 5 K min
−1
. In particular, photomicrographs presented in Figure 
4.39 and Figure 4.40 show changes in the geometric shape of the glass powder compact with 
 
respect to temperatures obtained from HSM. Table 4.9 summarizes the values of the temperature 
of first shrinkage (TFS; log  = 9.1 ± 0.1, is viscosity; dPa s), temperature for maximum 
shrinkage (TMS; log = 7.8 ± 0.1) and ratio of the final area/initial area of the glass powder 
compact (A/A0) as obtained from the HSM data at TMS (Figure 4.38) along with temperature for 
onset of crystallization (Tc) and peak temperature of crystallization (Tp), as obtained from DTA 
thermograph of the glasses. In all the investigated compositions, sintering preceded 
crystallization, thus resulting in well sintered glass-ceramics. Table 4.9 lists the values of 
sinterability parameter (Sc), where Sc = Tc - TMS [13]. The parameter Sc is the measure of ability 
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Figure 4.38 Comparison of DTA and HSM curves on the same temperature scale for 
compositions (a) 1d, (b) 1d-b, (c) 1e and (d) 1e-c. 
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of sintering versus crystallization: the greater this difference, the more independent are the 
kinetics of both processes. In the present study, larger values of Sc (greater than 25 ºC) (74 - 99
 
ºC) are related with larger final densities, which indicate better sintering/crystallization 
behaviour. However, with respect to compositions, sintering ability degraded with increase in 
1d 
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Figure 4.39 HSM images of glasses with varying CaO/SiO2 ratio on alumina substrates at 
various stages of heating cycle. Heating rate: 5 K min
-1
. 
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  CaO/SiO2 ratio while it improved with increase in P2O5/CaF2 ratio in the glasses. Further, the 
values of Tc and Tp decreased with increase in CaO/SiO2 ratio in the glasses while they increased 
with increase in P2O5/CaF2 ratio (Table 4.9). It is noteworthy that DTA analysis of both the 
parent glass compositions i.e. 1d (Figure 4.38a) and 1e (Fig. 4.38c) exhibit a single exothermic 
curve. This anticipates that the glass-ceramic is formed either as a result of single phase 
crystallization or of an almost simultaneous precipitation of different crystalline phases. 
However, with increase in CaO/SiO2 ratio in the glasses a shoulder appeared in the main 
exothermic curve of glass 1d-b, thus pointing towards the formation of two different crystalline 
phases (Figure 4.38b). Similarly, an increase P2O5/CaF2 ratio in the glasses led to the appearance  
 
 
Figure 4.40 HSM images of glasses with varying P2O5/CaF2 ratio on alumina substrates at 
various stages of heating cycle. Heating rate: 5 K min
-1
. 
1e 
    
25 ºC 650 ºC 750 ºC 1200 ºC 
1e-a 
    
25 ºC 660 ºC 750 ºC 1200 ºC 
1e-b 
    
25 ºC 660 ºC 798 ºC 1200 ºC 
1e-c 
    
25 ºC 675 ºC 800 ºC 1200 ºC 
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of two distinct crystallization 
exothermic curves in glasses 
1e-b and 1e-c (Figure 4.38d), 
respectively. The activation 
energy of crystallization (Ec) 
(as obtained in accordance 
with our previous study [71]) 
increased with increasing 
P2O5 content in the glasses 
due to the increasing amount 
of glass network former, thus, 
providing stability against 
devitrification (Table 4.9). 
Furthermore, as is evident 
from Figure 4.39, increasing 
CaO content in the glasses at 
the expense of SiO2 increased 
 the refractoriness of the glass 
compositions, thus, increasing 
the flow temperature (TF; log 
 = 3.4± 0.1; dPa s) of the 
glasses 1d-a and 1d-b. The 
glasses from series 1e 
exhibited more refractory 
behaviour as no composition 
showed any deformation in 
the shape of the glass powder 
compacts until 1200 ºC, 
except decrease in area due to 
shrinkage. The increase in 
refractoriness of the materials with increasing P2O5 content is well known [67]. The half ball 
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Figure 4.41 X-ray diffractograms of glass-ceramics with 
varying (a) CaO/SiO2 ratio and (b) P2O5/CaF2 ratio after 
heat treatment at 825 ºC for 1 h. (Labels: Di, Diopside; FA, 
Fluorapatite; W, Wollastonite). The phase reflections 
corresponding to corundum have been left unmarked. 
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temperature (THB; log  = 4.1 ± 0.1) for glass 1d, as observed from photomicrographs obtained 
from HSM (Figure 4.40) is 1192 ºC while the flow temperature (TF) is 1197 ºC. 
 
In agreement with HSM and DTA results, well sintered glass-ceramics were obtained 
after heat treatment of powder compacts at 825 ºC for 1 h. The qualitative analysis of XRD 
diffractograms of glass-ceramics presented in Figure 4.41 revealed the crystallization of diopside 
(CaMgSi2O6; ICDD card: 78-1390), fluorapatite (Ca5(PO4)3F; ICDD card: 71-880) and 
wollastonite (CaSiO3; ICDD card: 72-2297) as the only crystalline phases in all the investigated 
compositions except glass-ceramic 1d-b where akermanite (Ca2MgSi2O7; ICDD card: 70-7162) 
also joined the crystalline phase assemblage. Table 4.10 presents the quantitative analysis of the 
crystalline phases present in all the investigated GCs as obtained from XRD analysis adjoined 
with Rietveld-R.I.R technique. Figure 4.42 shows the fit of a measured XRD pattern of a sintered 
GC by using the GSAS-EXPGUI software. The fitting to the measured X-ray diagram has been  
Figure 4.42 Observed (crosses), calculated (continuous line), and difference curve 
from the Rietveld refinement of the GC 1e-b heat treated at 825 ºC for 1 h in air. 
Markers representing the phase reflections correspond to corundum, fluorapatite, 
wollastonite and diopside (from top to bottom).  
 
130 
 
Table 4.10 Results of Rietveld-R.I.R quantitative analysis (wt%) 
 1d 1d-a 1d-b 1e 1e-a 1e-b 1e-c 
Diopside  44.60 (3) 49.97 (3) 17.51 (1) 46.57 (1) 47.42 (1) 53.13 (1)  51.40 (1) 
Wollastonite 16.07 (1) 12.60 (1) 4.95 (4) 6.82 (2) 14.03 (1) 10.55 (2) 0.92 (1)  
Fluorapatite 16.94 (1) 7.12 (4) 7.70 (1) 18.70 (2) 24.42 (1) 33.21 (1) 31.79 (3) 
Akermanite - - 37.69 (1) - - - - 
Glass 22.39 (5) 30.31 (8) 32.15 (7) 27.91 (5) 14.13 (3) 3.11 (4) 15.89 (5) 
Total 100 100 100 100 100 100 100 
2 3.07 5.26 5.38 13.18 5.90 7.57 5.731 
Rwp 0.13 0.17 0.17 0.12 0.08 0.09 0.08 
Rp 0.09 0.11 0.12 0.08 0.06 0.06 0.05 
 
performed by a least-square calculation. The calculated diagram (Figure 4.42) is based on 
crystallographic structure models, which also takes into account specific instrumental and 
samples effects. The parameters of this model have been refined simultaneously using least-
squares methods in order to obtain the best fit to all measured data. By least-squares refinement, 
a so-called figure-of-merit function R has been defined, which describes the residual (agreement) 
between observed and calculated data. It is noteworthy that many different statistical R factors 
have been proposed for judging the quality of a Rietveld refinement. The R factors show the 
mean deviation in accordance with the used model in per cent. The “profile R-factor”, Rp, and 
“weighted profile R-factor”, Rwp, for all the refinements are presented in Table 4.10. The values 
of Rwp as obtained in the present investigation are well in the limit of experimental accuracy. The 
difference plot in Figure 4.42 does not show any significant misfits. The differences under the 
main peaks of diopside, fluorapatite and wollastonite are caused by adjustment difficulties based 
on crystallinity of phases. As is evident from Table 4.10, diopside crystallized as the major 
crystalline phase in glass-ceramic 1d while the amount of wollastonite and fluorapatite remained 
almost constant. The increase in CaO/SiO2 ratio in glass 1d-a led to an increase in diopside and 
wollastonite content at the expense of fluorapatite in the resultant glass-ceramics. Further 
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addition of CaO in the glass system at the expense of SiO2 (1d-b) led to the crystallization of 
akermanite as the major phase followed by diopside, fluorapatite and wollastonite. It is 
noteworthy that akermanite based ceramics and glass-ceramics are potential biomaterials for 
bone regeneration and have been reported to exhibit excellent biocompatibility [72, 73]. The 
amount of glassy phase increased with increase in CaO/SiO2 ratio in the glass-ceramics. In case 
of glass compositions with varying P2O5/CaF2 ratio, the amount of diopside and fluorapatite 
increased with increase in P2O5 content in the glass system (Table 4.10) while the amount of 
amorphous glassy phase decreased until composition 1e-b. In general, all the resultant glass-
ceramics exhibit high degree of crystallization (glassy phase: 10-40%).  
 
  
 
  
 
 
In agreement with the XRD results, SEM images of all the glass-ceramics reveal a similar 
kind of microstructure (Figure 4.43) exhibiting different morphologies for different crystalline 
phases. Figure 4.43a presents the microstructure of the glass-ceramic 1d exhibiting rosette 
Figure 4.43 SEM images of fractured glass-ceramics after chemical etching with 2 
vol.% HF solution: a) 1d, (b) 1d-a, (c) 1e, (d) 1e-b  
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morphology which is typical for diopside crystals along with the dendritic crystal growth for 
another phase. Figure 4.43b presents the microstructure of the glass-ceramic 1d-b at lower 
magnification depicting a similar morphology of crystalline phases as was observed for glass-
ceramic 1d. Similar microstructure was observed for glass-ceramics 1e (Figure 4.43c), 1e-a, 1e-b 
(Figure 4.43d) and 1e-c, except that the size and amount of rosette shaped crystals (Figure 4.43c 
and 4.43d) increased, thus depicting an increase in the concentration of diopside in the glass-
ceramics. It should be mentioned here that due to very similar composition of crystalline phases 
present in glass-ceramics and considering the semi-quantitative nature of the energy dispersive 
spectroscopy (EDS) technique, we could not precisely distinct the microstructure for all the 
crystalline phases present in the glass-ceramics. 
4. Summary 
 An insight into the structure, sintering and crystallization behaviour of glasses in the 
CaO-MgO-SiO2-P2O5-Na2O-CaF2 system with varying CaO/SiO2 and P2O5/CaF2 molar ratio has 
been presented. The findings from this study are summarized below: 
1. The structure of the investigated glasses has some peculiar similarities with the structure 
of 45S5 glass since the Q
n
 (Si) units are dominated by Q
2
 and Q
3
 units.  
2. Sintering preceded crystallization in all the compositions, thus resulting in well sintered 
glass powder compacts with diopside as the major crystalline phase followed by 
fluorapatite and wollastonite.  
3. An increase in concentration of CaO at expense of SiO2 led to the formation of 
akermanite in the glass-ceramics. In general, an increase in P2O5/CaF2 and decrease in 
CaO/SiO2 ratio improves the sintering ability of glass powders. All the glass-ceramics 
exhibited high amount of crystallinity with total amorphous phase varying between ~ 3-
30 wt. %.  
Finally, the structural features and properties of synthesized glasses coupled with a 
possibility to produce well sintered glass-ceramics from corresponding glass-powder 
compacts might suggest testing new materials for further applications in biomedicine. 
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Our work aimed at understanding the composition-structure-property relationships in 
potentially bioactive glasses designed in CaOMgOP2O5SiO2F system. The main emphasis 
was on unearthing the influence of glass composition on molecular structure, sintering ability 
and bioactivity of phosphosilicate glasses. The parent glass compositions were designed in 
alkali-free system so as to maintain compositional disparity from widely studied 45S5 Bioglass
®
 
– based alkali-rich glass compositions. The compositional disparity from alkali-rich bioactive 
glass compositions was necessary in order to (i) negate the possibility of competing mechanism 
between sodium and calcium for coordination with phosphate component in the glass structure 
which is known to affect structure-property relationships in these glasses significantly [1], (ii) 
avoid preferential leaching of sodium from glass into aqueous solutions resulting in a rapid 
change in pH and solution chemistry, thus, affecting the results obtained from dissolution 
studies, (iii) avoid high crystallization tendency in glasses so as to understand the compositional 
impact on the sintering ability of glass powders [2]. 
The initial study focussed on exploring the structure, sintering ability and bioactivity of 
glasses along diopside (CaO•MgO•2SiO2) – fluorapatite (9CaO•3P2O5•CaF2) join. We could 
obtain glasses for compositions with (100–x) (CaO•MgO•2SiO2) – x(9CaO•3P2O5•CaF2), where 
x varied between 0 – 40 wt.%. While silicate glass network in all the glasses was dominated by 
Q
2
 units, phosphate component was majorly found coordinated in orthophosphate environment. 
While calcite formation masked the formation of carbonated-hydroxyapatite on glass surfaces 
when immersed in SBF (owing to the high glass powder – to – SBF ratio), increasing fluorapatite 
content in glasses had a marked effect on decreasing this tendency. The investigated glasses 
exhibited slower chemical dissolution in comparison to 45S5 Bioglass
®
, thus, resulting in slower 
pH changes in aqueous solutions. This trait is desired for aqueous colloidal processing of glass 
powders leading to the formation of porous glass-ceramic scaffolds. 
With respect to the sintering ability of the glass powders, shrinkage behaviour of glasses 
shifted from single stage–to–two stage due to the possible amorphous phase separation between 
silicate and phosphate phase in these glasses. This resulted in well sintered glass powders 
compacts with high amorphous content (>60 wt.%) for compositions with x = 10 and 20 wt.%. 
Diopside crystallized as the primary phase in all the glass-ceramics followed by fluorapatite as 
secondary/minor phase. The good sintering ability of glass powders along with crystallization of 
diopside will provide the resultant glass-ceramics with good mechanical stability and integrity 
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while high residual glassy phase will ensure good bioactivity and controlled degradation. The in 
vitro biological evaluation of these glass-ceramics (x = 10 – 20 wt.%) qualify them as potential 
materials for scaffold fabrication as well as for coatings on biomedical implants. 
Accordingly, the next studies focused on understanding the influence of compositional 
variations on structural, thermal and chemical properties of these glasses in an attempt to best 
optimize the parent compositions for their application in vitro and in vivo. While magnesium 
doping in glasses is best known to decrease their apatite forming ability owing to either its 
structural role as an intermediate oxide, thus increasing the polymerization in the glass network 
[3-5] or by competing with calcium for hydroxyapatite nucleation sites on the glass surface [6]; 
our work on influence of CaO/MgO ratio on sintering ability of diopside-fluorapatite glasses 
demonstrated degradation in sintering ability of investigated glasses with decreasing MgO 
content as the overall compositional chemistry shifted from diopside-fluorapatite binary join to 
diopside-fluorapatite-wollastonite (CaO•SiO2) ternary system. A glass composition with 39.32 
CaO – 13.60 MgO – 3.50 P2O5 – 42.41 SiO2 – 1.17 CaF2 (mol%) exhibited good sintering ability 
along with high residual glassy phase, thus qualifying for further experimentation as potential 
material for scaffold fabrication. 
Alkali (Na2O = 0 – 10 mol%) doping in these glasses at the expense of MgO resulted in 
interesting results where we could not observe significant influence of Na2O on the silicate glass 
network but competition between sodium and calcium for coordination with orthophosphate 
component in glass was highly evident from 
31
P NMR data, thus, showing the marked preference 
of alkali towards association with phosphate instead of silicate glass network in these glasses. 
Further, we experimentally validated the computational results of Tilocca [1] by demonstrating 
the preferential leaching of sodium over calcium from bioactive glasses in aqueous solutions and 
SBF, thus, inducing delayed hydroxyapatite formation and cellular apoptosis in vitro due to 
sudden outburst of alkali. Considering that conditions encountered by a biomaterial in vitro are 
significantly different than those encountered in vivo (static vs dynamic) and alkali-rich 45S5 
Bioglass
®
 has been used in >650,000 human patients [7], the concerns with cytotoxicity due to 
alkali-release from glasses may not be crucial for in vivo tissue engineering. However, they may 
not be the most suitable materials for application in in vitro tissue engineering. 
With respect to the sintering ability of glasses, incorporation of sodium in glasses in 
small concentrations (~4 mol%) facilitates their sintering resulting in glass-ceramics with  
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flexural strength of ~190 MPa. Increasing alkali content in promotes crystallization which 
hinders their sintering, thus, resulting in poorly sintered, porous and mechanically weak glass-
ceramics. 
In the final study where we investigated two different series of glass compositions i.e. 
one with varying CaO/SiO2 ratio and the second with varying P2O5/CaF2 ratio for their molecular 
structure and sintering ability. In both the cases, varying network modifier – to – network former 
ratio did exhibit considerable impact on the glass structure. In the first series of glasses, 
increasing CaO/SiO2 ratio effectively depolymerized the silicate glass network, while increasing 
P2O5/CaF2 ratio in second series of glasses resulted in polymerizing the silicate glass network. 
Interestingly, phosphate component in both the glass series remained almost unaffected. While 
depolymerizing the silicate glass network with increasing CaO/SiO2 ratio has been explained on 
the basis of increasing NBOs, increasing polymerization in silicate glass network with increasing 
P2O5/CaF2 ratio may be attributed to the increasing amorphous phase separation in silicate and 
phosphate component in glasses where the latter has ability to rip off network modifying cations 
from the silicate glass network, thus, forcing it to re-polymerize. With respect to sintering ability 
of glasses, increasing network modifier – to – network former ratio in glasses (CaO/SiO2 or 
CaF2/P2O5) deteriorated their sintering ability and increased their crystalline content which is 
undesired for glass-ceramic scaffold fabrication.  
 In conclusion, we have tried to elucidate the fundamental science governing the chemical 
dissolution, thermal stability and bioactivity of phosphosilicate glasses from the perspective of 
their composition-structure-property relationships. In our opinion, alkali-free glass-ceramics in 
diopside-fluorapatite system are suitable for scaffold fabrication for their application in in vitro 
tissue engineering while the excellent biological efficacy of our glass composition 4.33 Na2O  
30.30 CaO – 12.99 MgO – 2.60 P2O5 – 45.45 SiO2 – 4.33 CaF2 has been recently demonstrated 
[8]. 
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In this section of the thesis, it is helpful to appreciate the fact that — though composition 
– structure – property relationships in bioactive glasses have been studied for long time — most 
of the studies published in this domain are riddled with complexity that makes a holistic 
understanding deceptively difficult. While significant progress has been made in the area of 
understanding the atomic and molecular structure of bioactive glasses—thanks to advancement 
in experimental and computational probes to explore glass structure—similar comments cannot 
be made for experimental studies describing biodegradation and chemical dissolution behaviour 
of bioactive glasses. While the hypothesis of ‘apatite forming ability on glass surface in SBF as 
marker of bioactivity’ is still a topic of debate, especially with the advent of concept of third 
generation biomaterials, most experimental studies evaluating in vitro bioactivity and dissolution 
behaviour of glasses tend to neglect some crucial aspects like thermal history, surface 
preparation, solution chemistry and glass/media combinations that can lead to potential 
complications and non-meaningful results. Based on our experience during the course of doctoral 
research and review of relevant literature, we have come across at least three major concerns that 
need to be carefully addressed for future studies in order to understand the mechanisms 
governing the bioactivity of glasses and to allow the design of novel glass compositions for 
scaffold fabrication. 
(1) Surface chemistry of glasses: Since chemical dissolution (and bioactivity) of glass starts 
from the surface, the importance of surface chemistry in determining the dissolution kinetics of 
glasses cannot be neglected. However, considering the compositional complexity of 
multicomponent bioactive glasses, our understanding of the molecular structure of bioactive 
glass surfaces is very limited. In particular, it is rare to find an experimental or computational 
study describing the structural coordination of various moieties present on the glass surface and 
their impact on the macroscopic properties of bulk glass. Therefore, our future work will be 
focused mainly on understanding the influence of surface chemistry of glasses on their 
bioactivity.  
(2) Influence of solution chemistry – While the relevance of apatite forming ability in SBF is 
still controversial, the protocols for studying chemical degradation of bioactive glasses and 
ceramics as defined in various ISO standards need to be reviewed. Most of the ISO standards 
(for example, ISO 10993-14:2001 – Biological evaluation of medical devices: Identification and 
quantification of degradation products from ceramics; ISO 23317:2014 – Implants for surgery – 
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In vitro evaluation for the apatite-forming ability of implant materials) recommend the usage of 
buffered solutions in order to: (i) resist pH changes in the solution media due to glass dissolution; 
(ii) simulate the buffered fluids encountered by a biomaterial in human body. However, 
considering that (i) most of these experiments are conducted in static media and (ii) buffered 
aqueous solutions comprise mixture of both organic and inorganic salts, these experiments can 
be subject to complications that lead to significant error. Since the human physiological system 
is a dynamic system, the results obtained in static conditions do not simulate the actual 
conditions encountered by a biomaterial in vivo primarily due to errors generated by solution 
feedback effect. Further, organic ions in buffered solutions tend to chelate with silicate and 
aluminium ions (released from the glass into contact solution) while alkali ions already present in 
the solution tends to slow down the process of chemical dissolution by shifting the equilibrium 
of ion exchange reaction (≡Si – O – Na + H3O
+
 ⇋ ≡Si – OH + Na+ + H2O) towards the left, thus, 
affecting the overall dissolution kinetics and chemical degradation of the system. Therefore, new 
experimental protocols need be defined where solution chemistry has minimal impact on the 
dissolution kinetics of glasses. Our future work will also be focused in this direction. 
(3) Fabrication of glass-ceramic scaffolds by rapid prototyping:  With respect to fabrication 
of 3D porous glass-ceramic scaffolds for tissue engineering applications, recent advancements in 
the field of rapid prototyping (particularly with direct write assembly) have paved the way for 
fabrication of scaffolds with hierarchical pore structure. As discussed in this dissertation, we are 
at a stage where we have designed suitable glass composition with requisite properties desired 
for a scaffold. Further research in this domain will be focused on understanding the rheology of 
suspensions prepared from these glass compositions in order to create inks for direct write 
assembly. 
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